<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-archivearticle1.dtd?><?SourceDTD.Version 1.0?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">Nutr Neurosci</journal-id><journal-id journal-id-type="iso-abbrev">Nutr Neurosci</journal-id><journal-id journal-id-type="publisher-id">NNS</journal-id><journal-title-group><journal-title>Nutritional Neuroscience</journal-title></journal-title-group><issn pub-type="ppub">1028-415X</issn><issn pub-type="epub">1476-8305</issn><publisher><publisher-name>Maney Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">4485698</article-id><article-id pub-id-type="doi">10.1179/1476830513Y.0000000108</article-id><article-id pub-id-type="publisher-id">nns-18-145</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Environment, dysbiosis, immunity and sex-specific susceptibility: A translational hypothesis for regressive autism pathogenesis</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Mezzelani</surname><given-names>Alessandra</given-names></name><xref ref-type="aff" rid="af1">1</xref><xref ref-type="corresp" rid="cor1"/></contrib><contrib contrib-type="author"><name><surname>Landini</surname><given-names>Martina</given-names></name><xref ref-type="aff" rid="af1">1</xref></contrib><contrib contrib-type="author"><name><surname>Facchiano</surname><given-names>Francesco</given-names></name><xref ref-type="aff" rid="af2">2</xref></contrib><contrib contrib-type="author"><name><surname>Raggi</surname><given-names>Maria Elisabetta</given-names></name><xref ref-type="aff" rid="af3">3</xref></contrib><contrib contrib-type="author"><name><surname>Villa</surname><given-names>Laura</given-names></name><xref ref-type="aff" rid="af3">3</xref></contrib><contrib contrib-type="author"><name><surname>Molteni</surname><given-names>Massimo</given-names></name><xref ref-type="aff" rid="af3">3</xref></contrib><contrib contrib-type="author"><name><surname>De Santis</surname><given-names>Barbara</given-names></name><xref ref-type="aff" rid="af2">2</xref></contrib><contrib contrib-type="author"><name><surname>Brera</surname><given-names>Carlo</given-names></name><xref ref-type="aff" rid="af2">2</xref></contrib><contrib contrib-type="author"><name><surname>Caroli</surname><given-names>Anna Maria</given-names></name><xref ref-type="aff" rid="af4">4</xref></contrib><contrib contrib-type="author"><name><surname>Milanesi</surname><given-names>Luciano</given-names></name><xref ref-type="aff" rid="af1">1</xref></contrib><contrib contrib-type="author"><name><surname>Marabotti</surname><given-names>Anna</given-names></name><xref ref-type="aff" rid="af3">3</xref></contrib></contrib-group><aff id="af1"><label>1</label>Institute for Biomedical Technologies, National Research Council, Via Fratelli Cervi 93, 20090 Segrate (MI), Italy</aff><aff id="af2"><label>2</label>Istituto Superiore di Sanit&#x000e0;, Rome, Viale Regina Elena 299, 00161 Roma, Italy</aff><aff id="af3"><label>3</label>IRCCS &#x0201c;E. Medea&#x0201d; &#x02013; Ass. &#x0201c;La Nostra Famiglia&#x0201d;, Via Don Luigi Monza, 20, 23842 Bosisio Parini (LC), Italy</aff><aff id="af4"><label>4</label>Dip. Scienze Biomediche e Biotecnologie, Universit&#x000e0; degli Studi di Brescia, Viale Europa 11, 25123 Brescia (BS), Italy</aff><author-notes><corresp id="cor1">Correspondence to: Alessandra Mezzelani, Institute for Biomedical Technologies, National Research Council, Milan, Segrate, Italy. Email: <email>alessandra.mezzelani@itb.cnr.it</email></corresp></author-notes><pub-date pub-type="ppub"><month>5</month><year>2015</year><string-date>May, 2015</string-date></pub-date><volume>18</volume><issue>4</issue><fpage>145</fpage><lpage>161</lpage><permissions><copyright-statement>&#x000a9; W. S. Maney &#x00026; Son Ltd 2015</copyright-statement><copyright-year>2015</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0/"><license-p>MORE OpenChoice articles are open access and distributed under the terms of the Creative Commons Attribution License 3.0</license-p></license></permissions><self-uri content-type="pdf" xlink:href="nns-18-145.pdf"/><abstract><sec><title>Background</title><p>Autism is an increasing neurodevelopmental disease that appears by 3 years of age, has genetic and/or environmental etiology, and often shows comorbid situations, such as gastrointestinal (GI) disorders. Autism has also a striking sex-bias, not fully genetically explainable.</p></sec><sec><title>Objective</title><p>Our goal was to explain how and in which predisposing conditions some compounds can impair neurodevelopment, why this occurs in the first years of age, and, primarily, why more in males than females.</p></sec><sec><title>Methods</title><p>We reviewed articles regarding the genetic and environmental etiology of autism and toxins effects on animal models selected from PubMed and databases about autism and toxicology.</p></sec><sec><title>Discussion</title><p>Our hypothesis proposes that in the first year of life, the decreasing of maternal immune protection and child immune-system immaturity create an immune vulnerability to infection diseases that, especially if treated with antibiotics, could facilitate dysbiosis and GI disorders. This condition triggers a vicious circle between immune system impairment and increasing dysbiosis that leads to leaky gut and neurochemical compounds and/or neurotoxic xenobiotics production and absorption. This alteration affects the &#x02018;gut-brain axis&#x02019; communication that connects gut with central nervous system via immune system. Thus, metabolic pathways impaired in autistic children can be affected by genetic alterations or by environment&#x02013;xenobiotics interference. In addition, in animal models many xenobiotics exert their neurotoxicity in a sex-dependent manner.</p></sec><sec><title>Conclusions</title><p>We integrate fragmented and multi-disciplinary information in a unique hypothesis and first disclose a possible environmental origin for the imbalance of male:female distribution of autism, reinforcing the idea that exogenous factors are related to the recent rise of this disease.</p></sec></abstract><kwd-group><kwd>Environmental autism</kwd><x xml:space="preserve">, </x><kwd>Gut dysbiosis</kwd><x xml:space="preserve">, </x><kwd>Immune system</kwd><x xml:space="preserve">, </x><kwd>Sex bias</kwd><x xml:space="preserve">, </x><kwd>Xenobiotics</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="s1"><title>Introduction</title><p>Autism spectrum disorder (ASD) is a neurodevelopmental disorder with uncertain etiology, characterized by social deficits, communication difficulties, stereotyped or repetitive behaviors, and in some cases, cognitive delays.<sup><xref rid="C1" ref-type="bibr">1</xref></sup></p><p>ASD shows a striking sex bias, with a male:female ratio estimated at 3&#x02013;4:1, and it usually appears by 3 years of age. Some authors have stated that ASD children often have relatively normal development during the first 12&#x02013;24 months of life; then, after a period of regression, the full syndrome becomes evident.<sup><xref rid="C2" ref-type="bibr">2</xref></sup></p><p>The prevalence of ASD varies among countries and it has increased dramatically in the last decades, reaching 6&#x02013;7 per 1000 individuals and even more in English-speaking countries. This rise is only partially explained by changes in diagnostic criteria.<sup><xref rid="C3" ref-type="bibr">3</xref></sup></p><p>Genetics is considered to play a relevant role in ASD, but only 16&#x02013;17% of autistics are carriers of a known genetic variant, and only few common alterations have been recognized as candidate genes in linkage and association studies.<sup><xref rid="C1" ref-type="bibr">1</xref></sup> Moreover, the gender distribution of the disease would seem to reflect a genetic X-linked pattern, but very few X-linked forms of autism susceptibility have been found to date. Therefore, in addition to genetics, possible environmental causes such as pathogens, use of antibiotics, heavy metals, chemicals, and toxins have been proposed,<sup><xref rid="C4" ref-type="bibr">4</xref></sup> although in some cases their involvement has been or is still considered controversial. However, none of these factors alone can explain why only few children are sensitive to these environmental effects, why these effects occur in the first 3 years of age, and why males are more sensitive than females.</p><p>In many patients, some other diseases, such as epilepsy, metabolic defects, sleep problems, and gastrointestinal (GI) disorders are in co-morbidity with autism and, interestingly, GI disorders have a strong correlation with the severity of the disease.<sup><xref rid="C5" ref-type="bibr">5</xref>,<xref rid="C6" ref-type="bibr">6</xref></sup></p><p>By collecting data from the literature and organizing fragmented hypotheses, we obtained a unique overview and formulated a hypothesis that tries to explain the sequence of possible causative events for regressive autism development. This hypothesis suggests how, in children not yet immune-competent, GI disorders and alterations of the intestinal ecosystem (gut dysbiosis) can establish, causing the synthesis of neuro-active molecules, leaky gut, and then neurotoxic xenobiotics (compound foreign to a living organism) production and absorption. We also found that, in animal models, some of these substances play a male-dependent neurodevelopment damage, thus reinforcing the environmental hypothesis for regressive autism. The combination of these factors, especially during infancy in which brain's sensitivity to senses and learning must be specifically timed,<sup><xref rid="C7" ref-type="bibr">7</xref></sup> could lead to the development of ASD in vulnerable children. Our hypothesis can be the starting point for the prevention of all the conditions predisposing to dysbiosis and neurotoxic xenobiotics absorption, for the planning of probiotics and/or specific antimicrobial therapies, and to establish the toxin risk assessment and the daily tolerable intake.</p></sec><sec sec-type="discussion" id="s2"><title>Discussion</title><sec id="s2a"><title>Gut and microbiota</title><sec id="s2a1"><title>The role of microbiota in human health</title><p>An increasing number of evidences point to the importance of the so-called &#x02018;gut&#x02013;brain axis&#x02019; revealing the central role of the gut microbiota (the new denomination of &#x02018;microflora&#x02019;), in the post-natal development and maturation of the immune and endocrine systems that, in turn, control the central nervous system (CNS) signaling, brain functions, and behavior.<sup><xref rid="C8" ref-type="bibr">8</xref>&#x02013;<xref rid="C10" ref-type="bibr">10</xref></sup></p><p>The gut resident commensal microorganisms consist essentially of prokaryotes, especially bacteria, and of a minor component of archaea, viruses, and eukaryotes such as fungi.</p><p>The healthy, balanced gut communities state is called &#x02018;eubiosis&#x02019;, and in adulthood is dominated by the phyla <italic>Firmicutes</italic> and <italic>Bacteroidetes</italic> followed by <italic>Actinobacteria</italic> and <italic>Proteobacteria</italic>. These microorganisms have structural and protective functions for humans, such as the intestinal wall formation, the development of both immune and endocrine systems, the increasing resistance to pathogen colonization, the detoxification and degradation of xenobiotics, the production of short-chain fatty acids (acetate, propionate, and butyrate) and vitamins, nutrient absorption, and amino acid synthesis from ammonia or urea.<sup><xref rid="C11" ref-type="bibr">11</xref>&#x02013;<xref rid="C13" ref-type="bibr">13</xref></sup> The fermentation of non-digestible carbohydrates by intestinal microbiota, leading to the production of short-chain fatty acids, has a role in several processes in the gut, such as cell proliferation and differentiation, ions and water adsorption, hormone secretion, and cytokines production (tumor necrosis factor-alpha (TNF-&#x003b1;), interleukin (IL)-2, IL-6, IL-10) that, in turn, activate the immune systems and regulate the leukocyte function. Moreover, by competing for the space and nutrients and by producing antimicrobial substances, commensal bacteria can effectively inhibit the growth and the proliferation of pathogens, contributing to maintain a healthy and well-balanced gut microbiota.<sup><xref rid="C13" ref-type="bibr">13</xref>,<xref rid="C14" ref-type="bibr">14</xref></sup></p><p>Among the commensal bacteria, <italic>Bifidobacteria</italic> are generally considered among the most relevant beneficial bacteria and, apart from variations due to diet and age, they represent roughly the 10% of the human adult microbiota. In infants, however, a higher proportion of <italic>Bifidobacteria</italic> has been reported and strictly associated to an appropriate development of the immune system.<sup><xref rid="C15" ref-type="bibr">15</xref></sup> Together with <italic>Lactobacilli</italic>, including those derived from breast milk, <italic>Bifidobacteria</italic> contribute to a healthy infant gut, by modulating both natural and acquired immune response.<sup><xref rid="C15" ref-type="bibr">15</xref></sup> On this regard, it has been reported that <italic>Lactobacillus salivarius</italic> and <italic>Lactobacillus fermentus</italic> enhance Type 1 helper T cells cytokines production, such as IL-2 and IL-12 as well as modulate the expression of the inflammatory mediator TNF-&#x003b1;.<sup><xref rid="C16" ref-type="bibr">16</xref></sup> More generally, it is well stated that, especially in animal models, lactic acid bacteria can enhance natural immunity by increasing the non-specific phagocytic cell function as well as cytokines, interferons, and interleukins production.<sup><xref rid="C14" ref-type="bibr">14</xref>,<xref rid="C17" ref-type="bibr">17</xref></sup></p><p>Furthermore, human milk <italic>Lactobacillus</italic> strains drastically reduce (up to 46%) GI infections, as well as the general incidence rates of infections in newborns, such as those of the upper respiratory tract. Among Firmicutes, <italic>Viridans streptococci</italic>, and commensal staphylococci, both supplied by breast milk, help to keep under control the infection of <italic>Staphylococcus aureus</italic>, representing a high risk for newborns.<sup><xref rid="C16" ref-type="bibr">16</xref>,<xref rid="C18" ref-type="bibr">18</xref></sup> In addition, studies carried on mice have been reported that lactic acid bacteria could also inhibit the GI epithelium colonization of <italic>Candida albicans</italic>, whose overgrowth, if not properly counteracted by commensal bacteria, can trigger a severe infection on mucosal surfaces.<sup><xref rid="C19" ref-type="bibr">19</xref></sup> As by-products of fermentation, <italic>Lactobacillus</italic> strains produce a large amount of short-chain fatty acids, such as the butyric acid, that can effectively inhibit <italic>C. albicans</italic> hyphal transformation, the first step for commensal to pathogen switch, leading to hyphal invasion and the systemic infection.<sup><xref rid="C19" ref-type="bibr">19</xref>&#x02013;<xref rid="C21" ref-type="bibr">21</xref></sup></p><p>Finally, both <italic>Bifidobacteria</italic> and <italic>Lactobacilli</italic> contribute to keep an appropriate microbial homeostasis, by increasing the production of functional metabolites, such a butyrate, the main energy source of colonocytes, and by modulating the breakdown of sugars and proteins, key compounds for the intestinal function.<sup><xref rid="C16" ref-type="bibr">16</xref></sup></p></sec><sec id="s2a2"><title>Dysbiosis and GI disorders in ASD children</title><p>The development of next generation sequencing techniques has permitted to define the entire human microbioma (the genome identification of a microbiota). The pyrosequencing analysis of the 16S bacterial hyper-variable regions has discovered many species of bacteria that have never been cultured nor described previously.<sup><xref rid="C22" ref-type="bibr">22</xref></sup></p><p>In this regard, several studies have been carried out in an attempt to profile the ASD microbiota, in comparison with healthy siblings and/or unrelated controls.<sup><xref rid="C6" ref-type="bibr">6</xref>,<xref rid="C22" ref-type="bibr">22</xref>&#x02013;<xref rid="C24" ref-type="bibr">24</xref></sup> Despite few studies reported small or no differences in the gut microbiota composition between ASD children and their unaffected siblings,<sup><xref rid="C24" ref-type="bibr">24</xref>,<xref rid="C25" ref-type="bibr">25</xref></sup> the imbalance in the microbial gut composition in ASD samples is well stated, especially when compared with unrelated healthy controls.<sup><xref rid="C6" ref-type="bibr">6</xref>,<xref rid="C22" ref-type="bibr">22</xref>,<xref rid="C23" ref-type="bibr">23</xref>,<xref rid="C26" ref-type="bibr">26</xref>,<xref rid="C27" ref-type="bibr">27</xref></sup></p><p>The meta-genomics analyses of stools from ASD patients, in fact, have revealed that ASD microbioma is significantly different from that of controls and consists of over 1000 different species in comparison with the 530 ones of healthy children.<sup><xref rid="C22" ref-type="bibr">22</xref></sup> Moreover, among phyla, ASD patients have under-represented most of Firmicutes and Actinobacteria, especially <italic>Bifidobacteria</italic>, and over-represented most of Bacteroidetes and Proteobacteria with respect to controls (Fig.&#x000a0;<xref ref-type="fig" rid="F1">1</xref>).<sup><xref rid="C22" ref-type="bibr">22</xref>,<xref rid="C27" ref-type="bibr">27</xref>,<xref rid="C28" ref-type="bibr">28</xref></sup> Decreasing of <italic>Bifidobacteria</italic> that help children to develop innate immunity, in ASD microbiota, can explain pathogens overgrowth. Although Firmicutes are under-represented in their complex, the class of <italic>Clostridia</italic> is more abundant in ASD children with GI disorders. These bacteria are considered the most attractive responsible for the development of autism: many of them are virulent and producing toxins and antimicrobial, oxygen, and drying-resistant spores.<sup><xref rid="C23" ref-type="bibr">23</xref>,<xref rid="C29" ref-type="bibr">29</xref></sup> Interestingly, many autistic symptoms ameliorate during oral vancomycin treatment but relapse after the agent is discontinued.<sup><xref rid="C26" ref-type="bibr">26</xref></sup> Oral vancomycin is not absorbed from the intestinal wall and exerts its action exclusively on gut microbiota highlighting the crucial role of the bowel bacterial flora. Indeed, the relapse and persistence of the <italic>Clostridia</italic> after discontinuation of vancomycin is probably due to germination of spores,<sup><xref rid="C29" ref-type="bibr">29</xref></sup> as well as the relapse of autistic symptoms is imputable to <italic>Clostridia</italic> re-overgrowth.</p><fig id="F1" orientation="portrait" position="float"><label>Figure 1<x xml:space="preserve">&#x000a0;</x></label><caption><p>The gut microbial composition and development in healthy and autistic children. Asterisks refer to a higher (**) or low abundance (*) of microbial flora in an infant healthy gut. Arrows, instead, indicate the increase (&#x02191;) or decrease (&#x02193;) of gut microbial components according to C-section, breast or formula feed, ASD. ASD, autism spectrum disorder; C-section, cesarean section. <sup>1</sup>Data by Finegold <italic>et al.</italic><sup>27</sup>.</p></caption><graphic xlink:href="nns-18-145.01"/></fig><p>Recently, <italic>Desulfovibrio</italic>, a genus of Gram-negative sulfate-reducing bacteria, was found in 50% of autistic stools and in that of some siblings but not at all in controls. This sulfate-reducing and lipopolysaccharides (LPS)-producing bacterium could be responsible for the aberrant sulfur metabolism and to the high level of serum endotoxins described in ASD subjects. Despite not spore formers, <italic>Desulfovibrio</italic> can escape antibiotic treatments traveling, by its flagellum, within intestinal biofilm that protect it from peristalsis, antibiotics, and host defenses.<sup><xref rid="C27" ref-type="bibr">27</xref></sup></p><p>Interestingly, although Bacteroidetes are over-represented in ASD stools, a significantly lower presence of genus <italic>Prevotella</italic>, and other fermenters has been described in the gut of ASD children with GI disorders with respect to healthy controls. These microbial differences were more strictly correlated to the severity of autistic symptoms rather than to GI disorders or specific diet regimens.<sup><xref rid="C30" ref-type="bibr">30</xref></sup>
<italic>Prevotella</italic> not only has the ability to synthesize Vitamin B1, which mitigates ASD symptoms,<sup><xref rid="C31" ref-type="bibr">31</xref></sup> but it is also considered a central niche to maintain the community structure of human healthy gut microbiome.<sup><xref rid="C32" ref-type="bibr">32</xref>&#x02013;<xref rid="C34" ref-type="bibr">34</xref></sup> On the other hand, <italic>Propionibacterium</italic>, as well as <italic>Clostridia</italic> which are over-represented in ASD intestine, produces propionic acid,<sup><xref rid="C35" ref-type="bibr">35</xref>,<xref rid="C36" ref-type="bibr">36</xref></sup> a short-chain fatty acid, able to pass the gut&#x02013;blood and blood&#x02013;brain barriers (BBB) altering the neurophysiological processes by binding acetyl-CoA and sequestering acetyl-carnitine involved in mitochondrial lipid transport. Recent experiments demonstrated that administration of propionic acid to young rat models caused the development of mental delay with cognitive impairments, innate neuroinflammation response, and restricted/repetitive behavioral symptoms consistent with human autism.<sup><xref rid="C35" ref-type="bibr">35</xref></sup></p><p>Overgrowth of fungi, in particular of <italic>Candida</italic>, has also been reported as gut infection in some autistic patients,<sup><xref rid="C6" ref-type="bibr">6</xref>,<xref rid="C37" ref-type="bibr">37</xref>&#x02013;<xref rid="C41" ref-type="bibr">41</xref></sup> although no eukaryotic microorganism has been described in the most recent publications about autistic microbiota that had molecularly analyzed only the prokaryotic components.<sup><xref rid="C5" ref-type="bibr">5</xref>,<xref rid="C25" ref-type="bibr">25</xref>,<xref rid="C40" ref-type="bibr">40</xref>,<xref rid="C42" ref-type="bibr">42</xref></sup> In the gut of healthy individuals, <italic>Candida</italic> exist only in small colonies, kept under control by the human immune system and by eubiosis. If it becomes invasive, it produces root-like structures that push through the intestinal walls increasing gut permeability and leading to the so-called leaky-gut syndrome that allows exorphins and toxins to enter the bloodstream. These molecules then trigger food intolerance and allergies. In a recent work, candidiasis and leaky-gut syndrome correlate to a subset (36.7%) of autistic patients.<sup><xref rid="C43" ref-type="bibr">43</xref></sup></p><p>GI disorders affect individuals with ASD ranging widely from 9 to 70%, or higher, in different population studies, and show a strong correlation with the severity of the disease.<sup><xref rid="C5" ref-type="bibr">5</xref>,<xref rid="C6" ref-type="bibr">6</xref></sup> GI problems of autistic children include abdominal pain, diarrhea, constipation, bloating, increased intestinal permeability, and mucosal dysbiosis.<sup><xref rid="C5" ref-type="bibr">5</xref>,<xref rid="C42" ref-type="bibr">42</xref>,<xref rid="C43" ref-type="bibr">43</xref></sup> Typically, behavior symptoms and GI disturbances are manifest in parallel.<sup><xref rid="C25" ref-type="bibr">25</xref></sup></p><p>Recent findings have demonstrated that the previously described gut microbiota alterations correlate with these GI disturbances.<sup><xref rid="C6" ref-type="bibr">6</xref>,<xref rid="C22" ref-type="bibr">22</xref>,<xref rid="C25" ref-type="bibr">25</xref></sup> A series of events that can occur in the very first years of life, 0&#x02013;36 months, are able to alter the function and balance of gut microbiota, leading to immunological and neurological effects as we show in the following paragraphs (Fig.&#x000a0;<xref ref-type="fig" rid="F2">2</xref>).<sup><xref rid="C25" ref-type="bibr">25</xref>,<xref rid="C44" ref-type="bibr">44</xref></sup></p><fig id="F2" orientation="portrait" position="float"><label>Figure 2<x xml:space="preserve">&#x000a0;</x></label><caption><p>Differences between eubiosis (a healthy normal microflora) and dysbiosis establishment and consequences.</p></caption><graphic xlink:href="nns-18-145.02"/></fig></sec><sec id="s2a3"><title>Gut colonization</title><p>Fetal intestine is sterile until birth and its colonization, which occurs during birth, breastfeeding, and weaning, is essential for infant health. The microbial population becomes functional and steady over the time at around 3 years; before this age, infant gut microbiota is dynamic, malleable, and then relatively instable.<sup><xref rid="C45" ref-type="bibr">45</xref></sup> Causes that can hamper or damage eubiosis can be cesarean section, formula-feeding, early weaning, illness, the use of oral broad-spectrum antibiotics, and malnutrition. Many of these situations not only occur in the first 3 years of life, thus disturbing the assembly of a healthy microbiota,<sup><xref rid="C45" ref-type="bibr">45</xref></sup> but are also described as risk factors in ASD: (i) cesarean section (especially if scheduled) has a significantly higher frequency in mother of ASD children (27%) versus mother of healthy children (19.8%);<sup><xref rid="C46" ref-type="bibr">46</xref></sup> (ii) suboptimal or absence of breast-feeding and/or early weaning may increase the occurrence of ASD;<sup><xref rid="C47" ref-type="bibr">47</xref></sup> (iii) infections and the use of oral broad-spectrum antibiotics occur frequently before ASD manifestation.<sup><xref rid="C4" ref-type="bibr">4</xref></sup></p><p>Cesarean section deprives the newborn of contact with maternal vaginal microbiota leading to a deficiency of strict anaerobes such <italic>Lactobacillus</italic> and <italic>Prevotella</italic> and to an increase of facultative anaerobes from mother skin, especially <italic>Staphylococcus</italic>, <italic>Propionibacterium</italic>,<sup><xref rid="C48" ref-type="bibr">48</xref>&#x02013;<xref rid="C50" ref-type="bibr">50</xref></sup> and <italic>Clostridium</italic> species.<sup><xref rid="C48" ref-type="bibr">48</xref></sup></p><p>The gestational age of birth also influences the makeup of bowel flora, since the pattern of gut bacteria in preterm neonates differs from that of full-term newborns. Indeed, preterm newborns are hospitalized in neonatal intensive care units that routinely use formula milk and antibiotics. These practices have a negative impact on gut microbial colonization and could lead to food intolerance, to the development of necrotizing enterocolitis, and long-term neurodevelopment impairment.<sup><xref rid="C13" ref-type="bibr">13</xref>,<xref rid="C51" ref-type="bibr">51</xref></sup> Increased prevalence of ASD in children born preterm has also been described.<sup><xref rid="C52" ref-type="bibr">52</xref></sup></p><p>Furthermore, in early infancy, gut microbiota is mostly influenced by feeding: the bowel microbial composition is different between breast and formula-fed infants as well as between early and late weaning. Breast milk, containing antimicrobial molecules and prebiotic oligosaccharides, increases the beneficial component of <italic>Bifidobacteria</italic> and <italic>Lactobacilli</italic>, whereas formula milk increases the number of <italic>Enterococci</italic> and <italic>Enterobacteria</italic>.<sup><xref rid="C53" ref-type="bibr">53</xref>&#x02013;<xref rid="C56" ref-type="bibr">56</xref></sup></p><p>On the other hand, at around 12 months, maternal immune protection decreases while the child's own immune system is not yet competent, resulting in a high susceptibility to infections<sup><xref rid="C57" ref-type="bibr">57</xref>,<xref rid="C58" ref-type="bibr">58</xref></sup> (Fig.&#x000a0;<xref ref-type="fig" rid="F3">3</xref>).</p><fig id="F3" orientation="portrait" position="float"><label>Figure 3<x xml:space="preserve">&#x000a0;</x></label><caption><p>The critical window for immune vulnerability of children. At about 12 months the maternal protection is disappeared as well as antibodies from breastfeeding (especially in early weaning). On the other hand, the functionality and stability of gut microbiota as well as child's own antibodies formation are not yet reached.</p></caption><graphic xlink:href="nns-18-145.03"/></fig><p>Many infections, especially otitis that are among the most common bacterial infections of childhood,<sup><xref rid="C59" ref-type="bibr">59</xref>,<xref rid="C60" ref-type="bibr">60</xref></sup> are treated with oral broad-spectrum antibiotics that can perturb the gut microbiota. Moreover, many parents of autistics patients report episodes of otitis treated with oral broad-spectrum antibiotics before children manifest regressive autism symptoms, as well as some authors find ear canal malformation and/or hearing impairment more frequently in autistic children than in controls; somatic obstructions and malformation, in turn, may favor the onset of otitis and their complications.<sup><xref rid="C61" ref-type="bibr">61</xref></sup> Major microbial alterations were found after antibiotic treatments that lead to a long-term decrease of particular taxa.<sup><xref rid="C50" ref-type="bibr">50</xref>,<xref rid="C62" ref-type="bibr">62</xref>&#x02013;<xref rid="C64" ref-type="bibr">64</xref></sup> Even more seriously, the overuse of antibiotics can lead to an increase in antibiotic-resistant pathogens<sup><xref rid="C50" ref-type="bibr">50</xref>,<xref rid="C65" ref-type="bibr">65</xref></sup> and these phenomena have been considered as possibly related to the raise up of ASD incidence. For example, the analysis of the clinical history of 206 ASD children with no genetic alteration, birth trauma, or neurological diseases allowed to find that all of them have had recurrent bouts of otitis media treated with a mean number of 12.04 courses of clavulanic acid/amoxicillin.<sup><xref rid="C66" ref-type="bibr">66</xref></sup> Although these data are lacking appropriate aged-matched controls and the author has focused her discussion on the neurotoxic effect of urea, used in drug preparation, on brain tissue, the microbiota damage caused by antibiotics themselves should also be considered. Another factor, possibly related to the recent increase of ASD, is the broad antibiotic prophylaxis against group B streptococcal infections of the newborns from the positive mothers. This clinical practice that has led to a substantial reduction in the incidence of the group B <italic>Streptococcus</italic> infections,<sup><xref rid="C67" ref-type="bibr">67</xref></sup> it could, however, increase the risk of dysbiosis and then of gut&#x02013;brain axis alteration.</p><p>On the contrary, when ASD and GI disorders occur in parallel,<sup><xref rid="C25" ref-type="bibr">25</xref></sup> the use of dysbiosis-targeted antimicrobials and specific probiotics, to counteract gut pathogens overgrowth, not only ameliorates the GI disorders symptoms, but could also lead to cognitive and behavioral improvement.<sup><xref rid="C10" ref-type="bibr">10</xref>,<xref rid="C68" ref-type="bibr">68</xref>&#x02013;<xref rid="C73" ref-type="bibr">73</xref></sup></p><p>Moreover, almost 90% of ASD children experience feeding-related concern, especially food selectivity, with a strong preference for starches, processed food, snacks, and strong dislike for almost all vegetables and fruits and/or proteins.<sup><xref rid="C47" ref-type="bibr">47</xref>,<xref rid="C74" ref-type="bibr">74</xref></sup> The ability of feeding to regulate the microbiota composition and growth is already well known. Recently, microbiota was found to recognize and produce neuroendocrine hormones such as &#x003b3;-Aminobutyric acid (GABA) by <italic>Lactobacillus</italic> and <italic>Bifidobacterium</italic>, noradrenaline by <italic>Escherichia, Bacillus</italic>, and <italic>Saccaromices,</italic> serotonin by <italic>Candida, Streptococcus, Escherichia</italic>, and <italic>Enterococcus,</italic> dopamine by <italic>Bacillus</italic> and <italic>Serratia</italic>, and acetylcholine by <italic>Lactobacillus</italic>.<sup><xref rid="C75" ref-type="bibr">75</xref></sup> These compounds are absorbed in the bloodstream and/or interact with the vagus nerve. These findings have lead Norris <italic>et al.</italic>,<sup><xref rid="C76" ref-type="bibr">76</xref></sup> to propose a positive feedback loop hypothesis involving the host's food preferences and microbiota composition. Through this loop, nutrition influences gut microbiota that, in turn, produces neuroendocrine factors able to influence behavior (e.g. cognition), and food preferences.<sup><xref rid="C77" ref-type="bibr">77</xref></sup> To this purpose, the gut dysbiosis of ASD children can drive their food selectivity in order to &#x02018;feed&#x02019; pathogens and perpetuate their overgrowth.</p></sec><sec id="s2a4"><title>Neurodevelopment</title><p>The first periods of life (0&#x02013;36 months) are particularly delicate for the makeup of the gut complex community, and for immunity and neurodevelopment. Indeed, during this time, acquisition of many sensitive and cognitive processes pass through a &#x02018;critical&#x02019; period of elevated neuron plasticity, a specific time window of neurodevelopment during which experiences trig and sculpt the neural circuits involved in that process. Distinct critical periods occur in a hierarchical sequence, starting from primary sensory acquisition up to higher cognition. For example, social relationship and communication are linked to multisensory integration involving visual, auditory, and somatosensory. So, senses (vision, hearing, touch) and intellectual abilities (language, symbols, social relationships) develop, progress, and consolidate in these times of opportunity after which learning anything new becomes very difficult or impossible: if these periods are missed by early disruption or interferences of proper senses and/or social experiences, can no longer be recovered nor senses and skills be acquired.<sup><xref rid="C78" ref-type="bibr">78</xref>,<xref rid="C79" ref-type="bibr">79</xref></sup> In some ASD children sensory processes, such as sight and hearing or both of them, are often miswired due to somatic (ear canal malformation), functional, and infectious (otitis) causes, and the severity of sensory stimulation deprivation correlates with the severity of behavior and social relationship deficit.<sup><xref rid="C60" ref-type="bibr">60</xref>,<xref rid="C61" ref-type="bibr">61</xref>,<xref rid="C80" ref-type="bibr">80</xref>,<xref rid="C81" ref-type="bibr">81</xref></sup> Recent findings demonstrated that critical period depends on a perfect balance of cortical excitatory and inhibitory neurotransmission regulated by inhibitor neurotransmitters GABA.<sup><xref rid="C82" ref-type="bibr">82</xref>&#x02013;<xref rid="C84" ref-type="bibr">84</xref></sup> Interestingly, dysfunction in GABA transmitter system has already been described in autism<sup><xref rid="C85" ref-type="bibr">85</xref></sup> and a mistimed in the regulation of these critical periods has been proposed in the developing of ASD.<sup><xref rid="C7" ref-type="bibr">7</xref></sup></p></sec><sec id="s2a5"><title>Dysbiosis and xenobiotic production</title><p>The imbalance of microbiota composition in autistic children with GI disorders can lead to another consequence: the production of xenobiotic substances that can exert a negative systemic effect once entered the bloodstream. Indeed, a change in concentration of mammalian-microbial-cometabolites such as dimethylamine, hippurate, and phenylacetyl-glutamine has been found in the urine of ASD children.<sup><xref rid="C86" ref-type="bibr">86</xref></sup></p><p>Such pathogenic linkage was also suggested by Bolte,<sup><xref rid="C72" ref-type="bibr">72</xref></sup> that, starting from the evaluation of the clinical history of a child, speculated that autism could be due to a chronic tetanus infection of the intestinal tract. A possible migration, through a neural route, reaching and persistence of tetanus neurotoxin in the CNS was recently demonstrated by an experiment performed on cats: the transneuronal and transynaptic effect of the toxin injected into the medial rectus muscle of one eye causes a bilateral gaze palsy, revealing the changes in neuron connections due to the action of this neurotoxin on premotor neurons.<sup><xref rid="C87" ref-type="bibr">87</xref></sup></p><p>Moreover endotoxins, especially LPS of the outer membrane of Gram-negative bacteria, induce strong inflammation, leaky gut and leaky BBB disrupting the tight junctions of the brain microvascular endothelium, thus increasing paracellular permeability.</p><p>LPS endotoxins also inhibit P-glycoprotein, a transmembrane efflux transporter able to extrude a wide range of xenobiotics out of cells, thus causing an intracellular accumulations of these substances. This protein is localized at the luminal epithelial cell surfaces of the gut, liver, proximal tubules of the kidney, hematopoietic cells, and BBB.<sup><xref rid="C73" ref-type="bibr">73</xref>,<xref rid="C88" ref-type="bibr">88</xref>,<xref rid="C89" ref-type="bibr">89</xref></sup> Many diseases, including ASD, cognitive impairment, schizophrenia, Parkinson's, and Alzheimer's diseases, are associated with increased endotoxins in plasma.<sup><xref rid="C89" ref-type="bibr">89</xref>,<xref rid="C90" ref-type="bibr">90</xref></sup></p><p>Further support for the microbial metabolite hypothesis and for the key role of the bowel bacteria in autism came from the studies on autistic children treated with antibiotics and probiotics.<sup><xref rid="C91" ref-type="bibr">91</xref></sup> These evidences strongly suggest that autistic symptoms in ASD children with GI disturbances may be related to the production of neurotoxins by the gut microbiota. For example, antifungal drug therapy, such as the oral administration of nystatin, is a potential therapy in ameliorating ASD symptoms.<sup><xref rid="C38" ref-type="bibr">38</xref></sup> Based on the findings of abnormal urinary metabolites, including Krebs cycle metabolites, carbohydrates, and other compounds such as furan compounds, arabinose, tartaric, and citramalic acid, of putative microbial origin in ASD children, it has been reported that antifungal treatment in patients reduces both their clinical symptoms and the abnormal urinary secretion of some chemical compounds suggesting a link between an aberrant fungal or yeast overgrowth in the GI tract and their urinary metabolite profiles.<sup><xref rid="C38" ref-type="bibr">38</xref></sup> Despite any stool testing for yeast or fungi was performed in this study group and due to the small sample size, both elevated arabinose and tartaric acid could likely be associated to GI yeast overgrowth, such as <italic>C. albicans</italic>.<sup><xref rid="C38" ref-type="bibr">38</xref></sup> Subsequent studies have confirmed that microbial metabolism results in altered metabolite profiles in children with ASD.<sup><xref rid="C86" ref-type="bibr">86</xref>,<xref rid="C92" ref-type="bibr">92</xref>&#x02013;<xref rid="C94" ref-type="bibr">94</xref></sup> Recently, using a <sup><xref rid="C1" ref-type="bibr">1</xref></sup>H&#x02013;<sup><xref rid="C13" ref-type="bibr">13</xref></sup>C nuclear magnetic resonance approach, it has been attempted to profile the urine metabolites in ASD, for identifying some discriminating markers between autistics and controls.<sup><xref rid="C94" ref-type="bibr">94</xref></sup> Although the specificity of this new methodology needs to be validated in a larger dataset and on other developmental disorders, an increase in &#x003b2;-alanine, glycine, taurine, and succinate and, on the other hand, a decrease in creatinine and 3-methylhystidine have been reported in the urines of ASD children in comparison with controls.<sup><xref rid="C94" ref-type="bibr">94</xref></sup> High levels of tyrosine analog 3-(3-hydroxyphenyl)-3-hydroxypropionic acid, a bacterial <italic>m</italic>-tyrosine metabolite that induces characteristic autistic behavioral symptoms in rats, have been found in the urine of some ASD children. Its microbial origin is supported by its decrease in urine after patients were treated for clostridial infections with metronidazole.<sup><xref rid="C86" ref-type="bibr">86</xref>,<xref rid="C92" ref-type="bibr">92</xref></sup></p><p>Yeast and fungal infections caused by <italic>Aspergillus</italic> and <italic>Candida</italic> genus may be related to the production of the gliotoxin, a critical virulence determinant<sup><xref rid="C95" ref-type="bibr">95</xref></sup> of <italic>Aspergillus fumigatus,</italic> that has an important immunosuppressive activity, facilitating the fungal growth and the host colonization, through the induction of a local or generalized immunosuppression.<sup><xref rid="C96" ref-type="bibr">96</xref></sup> Moreover, <italic>Candida</italic> itself produces acetaldehyde by glucose fermentation; acetaldehyde acts on central dopaminergic system increasing dopamine levels in the nucleus accumbens, and forms &#x02018;false neurotransmitters&#x02019; by Schiff base formation with many aminic neurotransmitters.<sup><xref rid="C97" ref-type="bibr">97</xref></sup>
<italic>Candida</italic> also affects the immune system, inducing higher productions of the interleukins IL-6 and IL-8,<sup><xref rid="C98" ref-type="bibr">98</xref></sup> which were reported to be increased in the blood, brain, or cerebrospinal fluid of autistic subjects.<sup><xref rid="C99" ref-type="bibr">99</xref></sup></p></sec><sec id="s2a6"><title>Xenobiotics from food</title><p>Although there are only small-sized studies, some authors also found food protein exorphins and toxins in the fluids of ASD children.<sup><xref rid="C37" ref-type="bibr">37</xref>&#x02013;<xref rid="C39" ref-type="bibr">39</xref>,<xref rid="C68" ref-type="bibr">68</xref>,<xref rid="C86" ref-type="bibr">86</xref>,<xref rid="C92" ref-type="bibr">92</xref>,<xref rid="C100" ref-type="bibr">100</xref>&#x02013;<xref rid="C103" ref-type="bibr">103</xref></sup> In animal models, these xenobiotics interfere with immune, oxidant, and neurological systems suggesting that these substances can interfere also with CNS.<sup><xref rid="C35" ref-type="bibr">35</xref></sup></p><p>Exorphin xenobiotics, in particular, casomorphins from bovine &#x003b2;-casein and gliadinomorphines from wheat gluten, are opioid peptides which are formed by the degradation of food proteins, and that bind to opioid receptors inducing interferences in the dopaminergic, serotoninergic, and GABAergic pathways, thus affecting psychomotor development and emotional and motivated behavior.<sup><xref rid="C100" ref-type="bibr">100</xref>,<xref rid="C104" ref-type="bibr">104</xref>&#x02013;<xref rid="C106" ref-type="bibr">106</xref></sup> All these effects, known as &#x02018;opioid peptide excess&#x02019; theory, are relevant in schizophrenia and autism and confirmed by the improvement in attention and behavior obtained in autistic patients treated with the opioid receptor blocking naltrexone.<sup><xref rid="C107" ref-type="bibr">107</xref></sup> Increasing levels of exorphins also cause a fluctuating dopaminergic hyperfunction that, in animals, induces stereotypy as a typical feature.<sup><xref rid="C100" ref-type="bibr">100</xref></sup></p><p>With regards to the diet, it should be pointed out that specific genetic variants of bovine &#x003b2;-casein are associated with higher levels of casomorphines in milk.<sup><xref rid="C108" ref-type="bibr">108</xref></sup> Even if the European Food Safety Authority (EFSA) could not establish the cause&#x02013;effect relationship between the oral intake of &#x003b2;-casomorphins and the etiology of different human diseases including autism,<sup><xref rid="C109" ref-type="bibr">109</xref></sup> the potential lower production of casomorphins from milk carrying particular &#x003b2;-casein genetic variants or from different dairy species is an intriguing aspect which could be further taken into account in a casein-free diet planning.</p><p>Other toxic xenobiotics are mycotoxins, generated by food-contaminating microorganisms, especially fungi, that pollute the 25% of the world crop production.<sup><xref rid="C110" ref-type="bibr">110</xref></sup> The toxicity of some of these mycotoxins, such as ochratoxin A (OTA), fumonisin B1 (FB1), patulin, and gliotoxin, is well known.<sup><xref rid="C110" ref-type="bibr">110</xref>&#x02013;<xref rid="C114" ref-type="bibr">114</xref></sup> Indeed, mycotoxins can increase gut permeability: OTA and patulin alter intestinal functions and intestinal barrier and transport; some experiments have demonstrated that FB1 disturbs the sphingolipid biosynthesis pathway, altering intestinal epithelial cell proliferation and leading to a damage of the barrier function.<sup><xref rid="C115" ref-type="bibr">115</xref></sup> Finally, leaky gut also causes lower adsorption of nutrients, and, indeed, the deficiency of zinc, copper, and B6 vitamin was described in autistic children suffering from GI disorders.<sup><xref rid="C116" ref-type="bibr">116</xref></sup></p><p>OTA, produced by <italic>Aspergillus ochraceus</italic>, <italic>Aspergillus carbonarius</italic>, and <italic>Penicillium verrucosum</italic>, is one of the most diffused food-contaminating mycotoxin and it has been found to be implicated in the development of human and animal neurodegenerative diseases and brain dysfunction.<sup><xref rid="C113" ref-type="bibr">113</xref>,<xref rid="C117" ref-type="bibr">117</xref></sup></p><p>FB1, produced by <italic>Fusarium</italic> molds and mainly present in corn, causes neuronal tube defects in <italic>ex vivo</italic> mouse embryos. This effect is related to the folic acid receptor deficiency as a result of the FB1-dependent lipid rafts depletion.<sup><xref rid="C114" ref-type="bibr">114</xref></sup> Among other <italic>Fusarium</italic> toxins, deoxynivalenol, also known as vomitoxin, is diffused in cereals and, because of its adverse effect of inducing emesis in animals, it has been pointed out as possible serotoninergic and dopaminergic receptor agonist.<sup><xref rid="C118" ref-type="bibr">118</xref>&#x02013;<xref rid="C120" ref-type="bibr">120</xref></sup></p><p>Patulin, from <italic>Aspergillus</italic> and <italic>Penicillium</italic>, that induces behavioral effects in rats,<sup><xref rid="C121" ref-type="bibr">121</xref></sup> is the most common mycotoxin of apples, pears, and then of baby food such as apple and pear juice and purees,<sup><xref rid="C112" ref-type="bibr">112</xref></sup> thus easily contacts the intestinal tract of infants.</p><p>Gliotoxin is a mycotoxin of the epipolythiodioxopiperazine class of fungal toxins produced by a number of <italic>Penicillium</italic>, <italic>Aspergillus, Trichoderma</italic> as well as <italic>Gliocladium</italic>, <italic>Thermoascus</italic>, and <italic>Candida</italic> species.<sup><xref rid="C122" ref-type="bibr">122</xref></sup> Through its redox-sensitive transannular disulfide bridge, it exerts toxicity, for example, by conjugation to proteins and inactivation, by inhibiting nuclear factor kappa-light-chain enhancer of activated B-cells (NF-kB) transcription factor, and by generation of reactive oxygen species via redox cycling.<sup><xref rid="C122" ref-type="bibr">122</xref>&#x02013;<xref rid="C124" ref-type="bibr">124</xref></sup></p><p>Interestingly, several past and ongoing studies and anecdotal reports point out the positive cognitive and behavioral effects of the gluten-free-casein-free diet on ASD people, especially among children presenting GI disorders, food allergy diagnoses, and suspected food sensitivities.<sup><xref rid="C125" ref-type="bibr">125</xref></sup> However, because of contradictory results, further data are needed to address limitations of current research findings.<sup><xref rid="C126" ref-type="bibr">126</xref></sup> However, the efficacy of this diet could be explained by the fact that it avoids the absorption of both the most important food-derived exorphins (casomorphins and gliadinomorphines) and some mycotoxins, which often contaminate cereals and milk.</p><p>Another interesting correlation, still under debate, is between ASD and celiac disease and/or gluten intolerance.<sup><xref rid="C127" ref-type="bibr">127</xref>&#x02013;<xref rid="C129" ref-type="bibr">129</xref></sup> An intriguing correlation comes from the observation that the key molecular player in celiac disease, that is, the tissue transglutaminase enzyme<sup><xref rid="C130" ref-type="bibr">130</xref></sup> has also been reported to be strongly and specifically activated by tetanus and other clostridial toxins.<sup><xref rid="C131" ref-type="bibr">131</xref></sup> Furthermore, patients with ASD were found to be associated with an elevated autoantibody response to tissue transglutaminase.<sup><xref rid="C132" ref-type="bibr">132</xref></sup> A further support for this correlation is the effectiveness of the gluten-free-casein-free diet, whose mechanism of action is still mostly unexplained, for children diagnosed with ASD.<sup><xref rid="C125" ref-type="bibr">125</xref></sup> Finally, it is noteworthy that celiac disease, too, has recently shown a not completely explained increase of prevalence in the last decades.</p><p>These findings suggest that the clinical and molecular correlations between celiac and ASD diseases could be at least partially related to the activation of transglutaminase enzyme.</p></sec></sec><sec id="s2b"><title>Immune system</title><p>The neuro-immune communication, that connects immune system with CNS, is increasingly recognized. The mechanism for humoral-based neuro-immune interaction are numerous and complex and are regulated by the interface of the BBB, thus integrally belonging to the neuro-immune axis. LPS from Gram-negative bacteria and a high level of cytokines can pathologically disrupt BBB interfering with the equilibrium of the two systems.<sup><xref rid="C89" ref-type="bibr">89</xref></sup></p><p>Immune aberrations, with increased levels of cytokines, have been reported in autistic children especially in those with a regressive form of the disease.<sup><xref rid="C133" ref-type="bibr">133</xref></sup></p><p>Indeed, many proteins that were first discovered in the immune system were subsequently detected in the healthy, uninfected nervous system. For example, the neuronal expression profile of Major histocompatibility complex class 1 (MHC-I) proteins is dynamic during brain development and is spatially restricted throughout life, suggesting that a tight regulation may be necessary for normal neuronal functions. Neuronal MHC-I proteins are in turn modulated by increase and decrease in electrical activity and by the neuronal transcription factors CREB, NPAS4 (in inhibitory neurons), and MECP2 (in the neuron-derived cell line N2A).<sup><xref rid="C134" ref-type="bibr">134</xref></sup> Interestingly, mutation and dysregulation of CREB, NPAS4, and MECP2 have been found in autism.<sup><xref rid="C85" ref-type="bibr">85</xref>,<xref rid="C135" ref-type="bibr">135</xref></sup></p><p>Furthermore, analysis from post-mortem brains of ASD patients showed that the most consistently shared abnormality in gene expression patterns converge upon immune and enhanced oxidative stress and not upon neurodevelopmental genes, as it would be expected. Dysregulated immune responses accompanied by decreasing ATP production and/or increasing oxidative stress can potentially contribute in determining the onset and the severity of clinical symptoms, especially regression, mental retardation, and stereotypies.<sup><xref rid="C136" ref-type="bibr">136</xref></sup></p><p>Recently, an <italic>in silico</italic> analysis of gene expression profile from ASD involved genes in the healthy developing human brain highlighted a subset of genes mainly expressed in glial cells and strictly involved in the disorder via NF-kB, TNF, and JNK network that converge on central immune-cytokine signaling pathway.<sup><xref rid="C137" ref-type="bibr">137</xref></sup></p><p>Interestingly, environmental stimuli such as viruses, bacteria, or mycotoxins could interact with the inflammatory system in ASD via the induction of macrophages and the activation of NF-kB pathway.<sup><xref rid="C138" ref-type="bibr">138</xref></sup> In normal conditions, NF-kB transcription factor mediates the cellular response to exogenic stressors, both by enhancing the expression of inflammatory cytokines/chemokines, and by being induced by them, as in a positive feedback loop.<sup><xref rid="C139" ref-type="bibr">139</xref>,<xref rid="C140" ref-type="bibr">140</xref></sup> When NF-kB becomes aberrantly up-regulated, chronic or excessive inflammation is induced.<sup><xref rid="C140" ref-type="bibr">140</xref></sup> An increased expression of NF-kB and an aberrant expression of cytokines, which are, in turn, up-regulated by NF-kB itself, has been found in peripheral blood samples and in neurons, astrocytes, and microglia of ASD donors,<sup><xref rid="C141" ref-type="bibr">141</xref>,<xref rid="C142" ref-type="bibr">142</xref></sup> suggesting that ASD children may be unable to turn off the NF-kB stress-induced response.<sup><xref rid="C141" ref-type="bibr">141</xref></sup></p><p>Besides modulating inflammatory system, NF-kB is also involved in cell differentiation and proliferation. As for mycotoxins, in pig kidney cell lines, FB1-induced apoptosis is due to the inhibition of protein kinase C activity, and its downstream targets, NF-kB and TNF-&#x003b1;. The long-term NF-kB repression leads to a consequent induction of apoptosis.<sup><xref rid="C143" ref-type="bibr">143</xref></sup> Moreover, NF-kB can be also regulated by oxidative stress.<sup><xref rid="C141" ref-type="bibr">141</xref></sup> OTA, in fact, can induce nitrosative stress in macrophages, brain, kidney, and liver cells, through a NF-kB-dependent induction of inducible nitric oxide synthase (iNOS), an enzyme responsible for the production of nitric oxide. This leads to DNA damage, decrease in DNA repair activity, an increase in lipid peroxidation and, potentially, an impairment in the mitochondrial activity, with a marked toxicity on the nigro-striatal dopaminergic neurons.<sup><xref rid="C113" ref-type="bibr">113</xref>,<xref rid="C144" ref-type="bibr">144</xref></sup></p><p>Deoxynivalenol from <italic>Fusarium</italic> has been assessed to have effects on the transcription factors NF-kB<italic>,</italic> AP-1, and C/EBP&#x003b2;, which have binding sites in the promoters of numerous immune- and inflammation-related gene,<sup><xref rid="C145" ref-type="bibr">145</xref>&#x02013;<xref rid="C147" ref-type="bibr">147</xref></sup> increasing the synthesis of TNF-&#x003b1; and IL-6 and the induction of COX-2.<sup><xref rid="C148" ref-type="bibr">148</xref></sup> Interestingly, an enhanced oxidative stress in brain, as found in autistic cerebellum tissues, may affect neuronal differentiation, axonal targeting, and synapse formation.<sup><xref rid="C149" ref-type="bibr">149</xref></sup></p></sec><sec id="s2c"><title>Sex bias</title><p>Sex bias is one of the most reported detection in autism and, clearly, the identification of sex-specific pattern of gene expression can help in understanding the pathophysiology of the disorder.</p><p>Recently, Ziats and Rennert<sup><xref rid="C150" ref-type="bibr">150</xref></sup> re-analyzed the sex-specific gene expression profile obtained by a transcriptomic study of normal human brain development, with a combined bioinformatics approach. They found that genes with male-specific pattern of expression are involved in the processes of immune response, cell cytoskeleton, glycoproteins/extracellular matrix, and nucleosome/chromatin that, intriguing, are also implicated in ASD. As for immune response, it was exclusively significant at the expression level, not at the genetic ones, thus suggesting that immune alteration of ASD patients could be more environmental rather than genetics. Male brain development may be naturally more susceptible to environmental adverse events than female ones, as its normal development is more strictly dependent on immune-related pathway.</p><p>At environmental level, many toxins and compounds are described to act in a sex-specific manner.</p><p>Mycotoxins can have a greater impact on males. For instance, a gender-dependent difference in the incidence of OTA-induced neural tube defects in a mouse model was described.<sup><xref rid="C151" ref-type="bibr">151</xref></sup> It was speculated that these defects were due to the synergistic effect between altered BARX1 and SOX9 gene expressions. SOX9 is a transcription factor essential for skeletal development, but it is also involved in the development of the male phenotype,<sup><xref rid="C152" ref-type="bibr">152</xref></sup> thus contributing to the increased risk of autism in males. Interestingly, a recent study detected up-regulation of SOX9 in autistic cases.<sup><xref rid="C153" ref-type="bibr">153</xref></sup></p><p>As for FB1, it significantly affects the humoral immunity of male but not female rats<sup><xref rid="C154" ref-type="bibr">154</xref></sup> and depresses the pig immune response in a sex-specific manner, with males being more susceptible than females.<sup><xref rid="C155" ref-type="bibr">155</xref></sup></p><p>Genetic evidences supporting the role of sex steroids in the etiology of ASD have been already presented and explored.<sup><xref rid="C156" ref-type="bibr">156</xref>,<xref rid="C157" ref-type="bibr">157</xref></sup> A study showed significant association between autism spectrum quotient and empathy quotient with genes related with sex steroid synthesis and transport functions (e.g. ESR2 and CYP11B1).<sup><xref rid="C157" ref-type="bibr">157</xref></sup> More recently, a new candidate gene for autism, retinoic acid-related orphan receptor-alpha, a hormone-dependent receptor factor, has been introduced: its expression can be regulated by male and female hormones through their respective receptors, and one of its transcriptional targets is CYP19A1 (aromatase), an enzyme responsible for the conversion of testosterone to estrogen.<sup><xref rid="C158" ref-type="bibr">158</xref></sup> In this context, the xenobiotics may interfere on critical functions: zearalenone, for example, a <italic>Fusarium</italic> toxin commonly found in maize, is a potent estrogen-like toxicant acting as an estrogen agonist in the brain.<sup><xref rid="C159" ref-type="bibr">159</xref></sup></p><p>Concerning acetaldehyde, produced by <italic>Candida,</italic> a study about alcoholism described sex differences in peak acetaldehyde (the first metabolite of ethyl alcohol) concentration, with males showing a higher value than females.<sup><xref rid="C160" ref-type="bibr">160</xref></sup></p><p>Very recently, the key role of microbiota on gut&#x02013;brain axis was investigated and demonstrated using germ-free (GF) mice. Indeed these studies showed that, during early life, GF mice, especially males, manifest significant repetitive behaviors, social avoidance, and deficit that resemble those described in patients with neurodevelopment disorders such as autism. At biochemical level, GF mice presented altered monoamine neurotransmitter levels in the brain, imbalanced neurotrophin levels in the hippocampus and amygdala, increased serotonin level in the hippocampus, and increased neuroendocrine response to stress.<sup><xref rid="C9" ref-type="bibr">9</xref>,<xref rid="C161" ref-type="bibr">161</xref></sup> In order to reverse the social deficit, a post-weaning colonization of the gut of GF male mice was carried out and the social behavior was evaluated and compared with that of conventionally colonized mice. The results revealed that GF colonized mice regain the social motivations and interests for social novelty and regulate repetitive behaviors, thus underline the key role of microbiota in neurodevelopment and social behaviors. As these aspects are relevant in autism, that also has a similar male prevalence, they should be important clues for understanding the role of microbiota in the pathogenesis of the disorder and for planning novel therapies for microbial modifications,<sup><xref rid="C161" ref-type="bibr">161</xref></sup> such as probiotics and dietary interventions.</p><p>Also, sex-based differences in immunity are known, since human illnesses affect males and females differently. In general, both the proportion of individuals are infected, and the severity of infection are higher in males than females for viral, bacterial, fungal, and parasitic diseases.<sup><xref rid="C162" ref-type="bibr">162</xref>,<xref rid="C163" ref-type="bibr">163</xref></sup></p><p>Regarding the opioid peptides casomorphins, sex differences in opiate sensitivity have been demonstrated in multiple pre-clinical studies using pain models, and morphine resulted less potent in women compared with men. This is most likely due to differences in opiate receptor density, binding, and localization, as well as sex differences in the anatomy and physiology of opiate-responsive neural circuits.<sup><xref rid="C164" ref-type="bibr">164</xref>&#x02013;<xref rid="C166" ref-type="bibr">166</xref></sup> In animal models, the expression of &#x003bc;-opioid receptors in the ventro-lateral periaqueductal gray is sexually dimorphic and males have significantly higher levels of &#x003bc;-opioid receptors compared with females.<sup><xref rid="C167" ref-type="bibr">167</xref></sup></p></sec><sec id="s2d"><title>Critical analysis of literature</title><p>We have constructed this translational hypothesis for regressive autism pathogenesis assembling, in a complete and logical sequence, many articles and reviews containing different analyses and partial hypotheses for ASD etiology, spanning from genetics to environmental evaluations so as from clinical to pre-clinical studies.</p><p>Regarding genetics studies, many and consistent improvements in gene alteration analyses and discovery have been done since the newest technologies have been developed. Indeed, genome wide association has been applied to a great number of patients, thus allowing to find a robust correlation between genetic markers and specific clinical aspects of the disease. On the other hand, the development of next generation sequencing technologies has allowed to perform <italic>de novo</italic> sequencing, revealing new genes and new alterations causative of ASD. Unfortunately, the power and possibilities offered by these technologies in transcriptome analyses are, in ASD studies, limited to RNA from lymphoblastoid cells, as samples from CNS are, obviously, very rarely available.<sup><xref rid="C136" ref-type="bibr">136</xref>,<xref rid="C137" ref-type="bibr">137</xref></sup> However, in spite of the great progress in genetics analyses, only &#x0223c;17% of patients carry a genetic alteration unequivocally linked to ASD and very few of them can explain the male excess or the regression to autism that sometimes happen in healthy children between 12 and 36 months.</p><p>Many interesting articles about environmental causes of ASD have been published but none explained exhaustively why these agents can impair only few children, which are the predisposing conditions, why some healthy children progressively or suddenly regress to autism and why more males than females are involved. Moreover, some of them are contradictory and this may be due to the sized set and kind of samples analyzed: different age and clinical evaluations and, obviously, an over-representation of males (Table&#x000a0;<xref ref-type="table" rid="TB1">1</xref>).</p><table-wrap id="TB1" orientation="portrait" position="float"><label>Table 1<x xml:space="preserve">&#x000a0;</x></label><caption><p>Review analysis of literature regarding the most relevant environmental factors or stressors, associated to ASD</p></caption><alternatives><graphic xlink:href="nns-18-145.TB1"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Environmental factors/stressors</th><th align="center" rowspan="1" colspan="1">Relevant literature</th><th align="center" rowspan="1" colspan="1">Study type</th><th colspan="2" align="center" rowspan="1">Association with:<hr/></th><th align="center" rowspan="1" colspan="1">Main findings</th><th align="center" rowspan="1" colspan="1">Comments</th></tr><tr><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">ASD</th><th align="center" rowspan="1" colspan="1">ASD&#x000a0;+&#x000a0;GI disorders</th><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/></tr></thead><tbody><tr><td rowspan="1" colspan="1">Antibiotics</td><td rowspan="1" colspan="1">Sandler <italic>et al.</italic><sup><xref rid="C69" ref-type="bibr">69</xref></sup></td><td rowspan="1" colspan="1">Clinical</td><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">Short-term improvement after low doses of vancomycin and probiotic therapy in a sub-group of regressive ASD children</td><td rowspan="1" colspan="1">Small sample size. The reported improvements waned at follow-up. Further investigations are required</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Atlad&#x000f3;ttir <italic>et al.</italic><sup><xref rid="C59" ref-type="bibr">59</xref></sup></td><td rowspan="1" colspan="1">Clinical</td><td rowspan="1" colspan="1">No</td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">Population-based cohort study reporting no associations for ASD and mild infections, febrile episodes, or the use of antibiotics during pregnancy</td><td rowspan="1" colspan="1">Methodological limitations due to self-reported data/incomplete information</td></tr><tr><td rowspan="1" colspan="1">Diet and food xenobiotics</td><td rowspan="1" colspan="1">Batista <italic>et al.</italic><sup><xref rid="C129" ref-type="bibr">129</xref></sup></td><td rowspan="1" colspan="1">Clinical</td><td rowspan="1" colspan="1">No</td><td rowspan="1" colspan="1">No</td><td rowspan="1" colspan="1">No relevant associations among ASD, celiac disease, and glutein sensitivity</td><td rowspan="1" colspan="1">Poor diagnosis for ASD<break/>Because of the age of celiac disorder's onset is variable, it is possible that ASD patients would still develop this disease in the future</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Pennesi and Klein<sup><xref rid="C125" ref-type="bibr">125</xref></sup></td><td rowspan="1" colspan="1">Clinical</td><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">Effectiveness of glutein/casein free diet in a sub-group of ASD children</td><td rowspan="1" colspan="1">Retrospective study<break/>Potential diet errors</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Reichelt <italic>et al.</italic><sup><xref rid="C106" ref-type="bibr">106</xref></sup></td><td rowspan="1" colspan="1">Clinical</td><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">Finding of exorphins in urines of ASD children</td><td rowspan="1" colspan="1">Further studies are required to strengthen the role of bio-active peptides in ASD</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Critchfield <italic>et al.</italic><sup><xref rid="C71" ref-type="bibr">71</xref></sup></td><td rowspan="1" colspan="1">Review</td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">By comparing GI disorders in ASD and IBD, the supply of probiotics for ameliorating ASD symptoms is strongly encouraged</td><td rowspan="1" colspan="1">Need for pre-clinical/clinical trials</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Williams <italic>et al.</italic><sup><xref rid="C42" ref-type="bibr">42</xref></sup></td><td rowspan="1" colspan="1">Clinical</td><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">Insights between human gene expression and gut bacterial community composition.</td><td rowspan="1" colspan="1">Small sample size.</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Genuis <italic>et al.</italic><sup><xref rid="C128" ref-type="bibr">128</xref></sup></td><td rowspan="1" colspan="1">Clinical</td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">Glutein-free diet effectiveness in a 5-years-old child with ASD and suspected celiac disease</td><td rowspan="1" colspan="1">Case report</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Cass <italic>et al.</italic><sup><xref rid="C126" ref-type="bibr">126</xref></sup></td><td rowspan="1" colspan="1">Clinical</td><td rowspan="1" colspan="1">No</td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">Lack of evidence for opioid peptides in urine of male ASD children. No effectiveness for opioids in predicting or monitoring the effects of casein/glutein-free diet</td><td rowspan="1" colspan="1">No clinical evaluation for GI disorders in the samples. Further studies are required to validate the effectiveness of casein/glutein-free diet in ASD</td></tr><tr><td rowspan="1" colspan="1">Microbial metabolites/end-products</td><td rowspan="1" colspan="1">Frye and MacFabe<sup><xref rid="C36" ref-type="bibr">36</xref></sup></td><td rowspan="1" colspan="1">Clinical</td><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">Short-chain fatty acids and acetyl-carnitine abnormalities in ASD patients versus controls</td><td rowspan="1" colspan="1">Further studies are required to strength the similarity between animal models and ASD and to evaluate the role of microbiota as potential PPA source</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Mavel <italic>et al.</italic><sup><xref rid="C94" ref-type="bibr">94</xref></sup></td><td rowspan="1" colspan="1">Clinical</td><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">Aberrant urine metabolic profiling in ASD children versus controls by <sup><xref rid="C1" ref-type="bibr">1</xref></sup>H<sup><xref rid="C13" ref-type="bibr">13</xref></sup>C NMR</td><td rowspan="1" colspan="1">Needs for larger sample size<break/>Needs for testing the methodological specificity</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Kuwabara <italic>et al.</italic><sup><xref rid="C90" ref-type="bibr">90</xref></sup></td><td rowspan="1" colspan="1">Clinical</td><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">CE-TOFMS revealed aberrant metabolites, associated with oxidative stress and mitochondrial dysfunction, in the plasma of ASD adult males</td><td rowspan="1" colspan="1">Only adult males taking into account<break/>Needs for testing the methodological specificity and sensitivity</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Ming <italic>et al.</italic><sup><xref rid="C93" ref-type="bibr">93</xref></sup></td><td rowspan="1" colspan="1">Clinical</td><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">Altered gut microbial metabolites in urines of ASD children, with a stronger association in patients with GI disorders, suggesting a link between gut-dysbiosis and metabolic perturbances</td><td rowspan="1" colspan="1">No differences between ASD patients and controls have been found, by considering gender, diet, and vitamins supplementations.<break/>No evaluation for microbial gut-composition in ASD versus control children</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Kalu&#x0017c;na-Czapli&#x00144;ska and Blaszczyk<sup><xref rid="C39" ref-type="bibr">39</xref></sup></td><td rowspan="1" colspan="1">Clinical</td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">High levels of arabinose found in autistic children and positive effects of probiotics in reducing them</td><td rowspan="1" colspan="1">No controls evaluated.<break/>A possible involvement of <italic>Candida</italic> is suggested<break/>Preliminary study</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">MacFabe <italic>et al.</italic><sup><xref rid="C35" ref-type="bibr">35</xref></sup></td><td rowspan="1" colspan="1">Pre-clinical</td><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">Effects of propionic acid (PPA) in inducing autistic-like behaviors in male adolescent rats</td><td rowspan="1" colspan="1">These findings support further evidences on the effects of PPA in young rodents. Further works are required to validate this model in clinical studies</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Shaw<sup><xref rid="C92" ref-type="bibr">92</xref></sup></td><td rowspan="1" colspan="1">Clinical</td><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">Higher concentrations of HPHPA in the urine of ASD children, in comparison to aged-matched controls, and in one adult affected by <italic>C. difficile</italic> infection</td><td rowspan="1" colspan="1">No clinical evaluation for GI disorders in the samples. No analysis on the ASD stool samples</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Yap <italic>et al.</italic>, 2010<sup>102</sup></td><td rowspan="1" colspan="1">Clinical</td><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">Urinary metabolic alterations in ASD children versus siblings and controls identified by <sup><xref rid="C1" ref-type="bibr">1</xref></sup>H NMR, and potentially associated with gut disorders</td><td rowspan="1" colspan="1">No evaluation for gut microbiota in ASD samples.<break/>Needs for larger sample of early onset patients to clarify the role of these metabolic differences in the autism etiology</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Shaw <italic>et al.</italic><sup><xref rid="C38" ref-type="bibr">38</xref></sup></td><td rowspan="1" colspan="1">Clinical</td><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">Positive effect of the antifungal therapy in reducing fungal metabolites in ASD patients</td><td rowspan="1" colspan="1">No data reported about GI disorders or the analysis of stool samples</td></tr><tr><td rowspan="1" colspan="1">Gut microbiota</td><td rowspan="1" colspan="1">Gondalia <italic>et al.</italic><sup><xref rid="C24" ref-type="bibr">24</xref></sup></td><td rowspan="1" colspan="1">Clinical</td><td rowspan="1" colspan="1">No</td><td rowspan="1" colspan="1">No</td><td rowspan="1" colspan="1">Pyrosequencing analysis on ASD patients with and without GI disorders and siblings. No evidences for the involvement of gut dysbiosis in ASD</td><td rowspan="1" colspan="1">No evaluation for eukaryotic gut microbiota, viruses, or protozoa as well as for dietary differences among participants. Microbial end-products/metabolites should also be studied in the future</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Adams <italic>et al.</italic><sup><xref rid="C6" ref-type="bibr">6</xref></sup></td><td rowspan="1" colspan="1">Clinical</td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">Strong correlation with GI disorders and autism severity; lower levels of <italic>Bifidobacteria</italic> have been found in ASD patients versus healthy controls</td><td rowspan="1" colspan="1">No differences for yeasts was reported.<break/>Cultural and biochemical tests for microbiota profiling</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Finegold <italic>et al.</italic><sup><xref rid="C22" ref-type="bibr">22</xref></sup></td><td rowspan="1" colspan="1">Clinical</td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">Positive correlation with the highest levels of <italic>Bacteroide</italic>s in ASD children and autism severity. Significantly differences have been also found for <italic>Actinobacterium</italic> and <italic>Proteobacterium</italic></td><td rowspan="1" colspan="1">No differences between ASD patients and healthy siblings. No evaluation for the potential diet effects on gut microbiota</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Parracho <italic>et al.</italic><sup><xref rid="C25" ref-type="bibr">25</xref></sup></td><td rowspan="1" colspan="1">Clinical</td><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">Association between the high levels of <italic>Clostridium</italic> spp<italic>.</italic> and GI disorders in ASD patients versus healthy, unrelated, controls</td><td rowspan="1" colspan="1">No differences found between ASD patients and healthy siblings</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Song <italic>et al.</italic>, 2004<sup>23</sup></td><td rowspan="1" colspan="1">Clinical-methodol</td><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">Identification with Real-Time PCR of <italic>Clostridiales</italic> spp. in ASD stools</td><td rowspan="1" colspan="1">Small sample size. A comparison group of ASD patients with GI disorders was not included</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Finegold <italic>et al.</italic><sup><xref rid="C40" ref-type="bibr">40</xref></sup></td><td rowspan="1" colspan="1">Clinical</td><td rowspan="1" colspan="1">&#x02013;</td><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">Higher levels of <italic>Clostridium</italic> spp. in ASD feces versus healthy controls</td><td rowspan="1" colspan="1">Analysis of both fecal flora and gastric and small-bowel specimens. Small sample size</td></tr></tbody></table></alternatives><table-wrap-foot><fn><p>ASD, autism spectrum disorder; GI, gastrointestinal; IBD, intestinal bowel disease; PPA, propionic acid; HPHPA, 3-(3-hydroxyphenyl)-3-hydroxypropionic acid; NMR, nuclear magnetic resonance spectroscopy; CE-TOF-MS, capillary electrophoresis time-of-flight mass spectrometry.</p></fn></table-wrap-foot></table-wrap><p>Indeed, among the many possible and controversial environmental causes, we focused on the most emerging and convincing evidences and hypothesis: the involvement of gut dysbiosis in the etiology of the disease. Once supported only by poorly powered studies, describing very few cases, this hypothesis is now further supported by subsequent microbioma analyses: indeed, recent next generation sequencing meta-analyses<sup><xref rid="C22" ref-type="bibr">22</xref>,<xref rid="C91" ref-type="bibr">91</xref></sup> of stools from autistic patients revealed a microbioma imbalance that might explain the immune system alteration already described in ASD children, although the role of fungi is not taken into account.</p><p>On the other hand, the most studied and concordant literature refers to the involvement of immune system in ASD etiology: the involvement of cytokines and other pro-inflammatory compounds in ASD is already well-known.<sup><xref rid="C4" ref-type="bibr">4</xref>,<xref rid="C99" ref-type="bibr">99</xref>,<xref rid="C133" ref-type="bibr">133</xref></sup></p><p>Referring to sex disparity, one of the most typical issues in ASD, neither environmental studies nor those about molecular causes already published try to investigate this sex imbalance, making this issue still incomplete and unexplained. Therefore, in this regard, the studies about this topic are still lacking, making difficult to carry out a comprehensive critical analysis. However, we tried to further analyze how gene expression, immunological susceptibilities, and environmental stressors, such as xenobiotics, could affect mainly males than females, highlighting the role of environment, rather than genetics, in male-predisposing to ASD. Taking all these findings together, our hypothesis organizes partial and multidisciplinary scientific data and hypotheses in a timing sequence and in a logic way. It tries to explain what naturally happens in the first 3 years of life regarding the development and interaction of immune, gut-microbial, and nervous systems and what sequence of events can interfere with this harmonization causing regressive autism especially in males.</p></sec></sec><sec sec-type="conclusions" id="s3"><title>Conclusions</title><p>During the first 3 years of life, infant health is particularly vulnerable: at about 1 year the maternal immune protection decreases while the child's own immune system is not yet completely competent.<sup><xref rid="C57" ref-type="bibr">57</xref></sup> Also, the gut microbiota that protects against pathogens and interacts with immune system too is not entirely stable and working until 3 years. This creates a time window of particular vulnerability to infections that, especially if treated with broad-spectrum antibiotics, favors gut dysbiosis and GI disorders. In addition, the published reports highlighted the importance of antibiotic use/overuse and onset of ASD, indicating a 67% of probability of co-occurrence.<sup><xref rid="C72" ref-type="bibr">72</xref></sup> In our opinion, dysbiosis creates a vicious circle leading to a further impairment of the immune system, to the production of microbiota toxins and neurochemical compounds, to the reduction of detoxification, and to the leaky gut causing the adsorption of many xenobiotics (Fig.&#x000a0;<xref ref-type="fig" rid="F4">4</xref>). Some of them promote redox imbalance, intestinal permeability, immunosuppressant, and a sex-specific neurotoxicity, leading to the development of regressive autism, especially in males. This gender-related xenobiotics affect couples with a well-known intrinsic male vulnerability of the immune system.</p><fig id="F4" orientation="portrait" position="float"><label>Figure 4<x xml:space="preserve">&#x000a0;</x></label><caption><p>Suggested pathogenesis for autism. Genetic/immunological susceptibility and environmental risk factors could enhance gut dysbiosis, leading to an aberrant inflammatory response, to an abnormal production of microbial end-products, and to leaky gut. The latter can enhance mal-absorption of both microbial and exogenous xenobiotics derived from diet. Once absorbed in the bloodstream, all these compounds can affect the normal brain development and function both directly and impairing the immune system: the latter creates a loop, of aberrant gut&#x02013;brain axis communication that contributes to enhance these aberrant physiological responses. Finally, endogenous or exogenous stressors might have an impact in the development of senses, language, and higher cognitive functions developing and integrating in the first period of life.</p></caption><graphic xlink:href="nns-18-145.04"/></fig><p>In conclusion: (i) GI disorders should be an expression of an altered intestinal barrier depending on dysbiosis. This could lead to toxins production and adsorption, interfering with normal neurodevelopment in vulnerable children, causing their regression to autism; (ii) the metabolic pathways, altered in ASD children, could be affected by genetic defects or dysregulated by xenobiotics interference; (iii) some enterotoxins and food-xenobiotics promote a male-specific neurotoxicity, thus reinforcing a possible environmental origin for the ASD male excess and the recent rise of the disease prevalence; (iv) the genetic predisposition to microbiota effects and sensitivity to xenobiotics toxicity in males should be investigated, as well as the possible additive and/or synergistic effects of toxins on general population should be defined to establish the risk assessment and the daily tolerable intake.</p></sec></body><back><ack><title>Acknowledgements</title><p>This work has been supported by the Italian Ministry of Health (Targeted Research Funding in Public Health &#x02013; Young Researchers) GR-2009-1570296. A.M., M.L., and L.M. are supported also by the Italian Ministry of Education and Research (MIUR) through the Flagship project InterOmics (PB05), FIRB ITALBIONET (RBPR05ZK2Z), and HIRMA RBAP11YS7K.</p></ack><ref-list><title>References</title><ref id="C1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levy</surname><given-names>SE</given-names></name>, <name><surname>Mandell</surname><given-names>DS</given-names></name>, <name><surname>Schultz</surname><given-names>RT</given-names></name></person-group>
<article-title>Autism</article-title>. <source>Lancet</source>
<year>2009</year>;<volume>374</volume>:<fpage>1627</fpage>&#x02013;<lpage>38</lpage>.<pub-id pub-id-type="pmid">19819542</pub-id></mixed-citation></ref><ref id="C2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goldberg</surname><given-names>WA</given-names></name>, <name><surname>Osann</surname><given-names>K</given-names></name>, <name><surname>Filipek</surname><given-names>PA</given-names></name>, <name><surname>Laulhere</surname><given-names>T</given-names></name>, <name><surname>Laulhere</surname><given-names>T</given-names></name>, <name><surname>Jarvis</surname><given-names>K</given-names></name>, <etal><italic>et al.</italic></etal></person-group>
<article-title>Language and other regression: assessment and timing</article-title>. <source>J Autism Dev Disord</source>
<year>2003</year>;<volume>33</volume>:<fpage>607</fpage>&#x02013;<lpage>16</lpage>.<pub-id pub-id-type="pmid">14714930</pub-id></mixed-citation></ref><ref id="C3"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fombonne</surname><given-names>E</given-names></name></person-group>
<article-title>Epidemiology of pervasive developmental disorders</article-title>. <source>Pediatr Res</source>
<year>2009</year>;<volume>65</volume>:<fpage>591</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">19218885</pub-id></mixed-citation></ref><ref id="C4"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goines</surname><given-names>PE</given-names></name>, <name><surname>Ashwood</surname><given-names>P</given-names></name></person-group>
<article-title>Cytokine dysregulation in autism spectrum disorders (ASD): possible role of the environment</article-title>. <source>Neurotoxicol Teratol</source>
<year>2013</year>;<volume>36</volume>:<fpage>67</fpage>&#x02013;<lpage>81</lpage>.<pub-id pub-id-type="pmid">22918031</pub-id></mixed-citation></ref><ref id="C5"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Buie</surname><given-names>T</given-names></name>, <name><surname>Fuchs</surname><given-names>GJ</given-names></name>, <name><surname>Furuta</surname><given-names>GT</given-names></name>, <name><surname>Kooros</surname><given-names>K</given-names></name>, <name><surname>Levy</surname><given-names>J</given-names></name>, <name><surname>Lewis</surname><given-names>JD</given-names></name>, <etal><italic>et al.</italic></etal></person-group>
<article-title>Recommendations for evaluation and treatment of common gastrointestinal problems in children with ASDs</article-title>. <source>Pediatrics</source>
<year>2010</year>;<volume>125</volume><issue>Suppl 1</issue>:<fpage>S19</fpage>&#x02013;<lpage>29</lpage><pub-id pub-id-type="pmid">20048084</pub-id></mixed-citation></ref><ref id="C6"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adams</surname><given-names>JB</given-names></name>, <name><surname>Johansen</surname><given-names>LJ</given-names></name>, <name><surname>Powell</surname><given-names>LD</given-names></name>, <name><surname>Quig</surname><given-names>D</given-names></name>, <name><surname>Rubin</surname><given-names>RA</given-names></name></person-group>
<article-title>Gastrointestinal flora and gastrointestinal status in children with autism-comparisons to typical children and correlation with autism severity</article-title>. <source>BMC Gastroenterol</source>
<year>2011</year>;<volume>11</volume>:<fpage>22</fpage>.<pub-id pub-id-type="pmid">21410934</pub-id></mixed-citation></ref><ref id="C7"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rubenstein</surname><given-names>JLR</given-names></name>, <name><surname>Merzenich</surname><given-names>MM</given-names></name></person-group>
<article-title>Model of autism: increased ratio of excitation/inhibition in key neural systems</article-title>. <source>Genes Brain Behav</source>
<year>2003</year>;<volume>2</volume>:<fpage>255</fpage>&#x02013;<lpage>67</lpage>.<pub-id pub-id-type="pmid">14606691</pub-id></mixed-citation></ref><ref id="C8"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Collins</surname><given-names>SM</given-names></name>, <name><surname>Bercik</surname><given-names>P</given-names></name></person-group>
<article-title>The relationship between intestinal microbiota and the central nervous system in normal gastrointestinal function and disease</article-title>. <source>Gastroenterology</source>
<year>2009</year>;<volume>136</volume>:<fpage>2003</fpage>&#x02013;<lpage>14</lpage>.<pub-id pub-id-type="pmid">19457424</pub-id></mixed-citation></ref><ref id="C9"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clarke</surname><given-names>G</given-names></name>, <name><surname>Grenham</surname><given-names>S</given-names></name>, <name><surname>Scully</surname><given-names>P</given-names></name>, <name><surname>Fitzgerald</surname><given-names>P</given-names></name>, <name><surname>Moloney</surname><given-names>RD</given-names></name>, <name><surname>Shanahan</surname><given-names>F</given-names></name>, <etal><italic>et al.</italic></etal></person-group>
<article-title>The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner</article-title>. <source>Mol Psychiatry</source>
<year>2013</year>;<volume>18</volume>:<fpage>666</fpage>&#x02013;<lpage>673</lpage>.<pub-id pub-id-type="pmid">22688187</pub-id></mixed-citation></ref><ref id="C10"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cryan</surname><given-names>JF</given-names></name>, <name><surname>Dinan</surname><given-names>TG</given-names></name></person-group>
<article-title>Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour</article-title>. <source>Nat Rev Neurosci</source>
<year>2012</year>;<volume>13</volume>:<fpage>701</fpage>&#x02013;<lpage>12</lpage>.<pub-id pub-id-type="pmid">22968153</pub-id></mixed-citation></ref><ref id="C11"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fuchs</surname><given-names>S</given-names></name>, <name><surname>Sontag</surname><given-names>G</given-names></name>, <name><surname>Stidl</surname><given-names>R</given-names></name>, <name><surname>Ehrlich</surname><given-names>V</given-names></name>, <name><surname>Kundi</surname><given-names>M</given-names></name>, <name><surname>Knasmuller</surname><given-names>S</given-names></name></person-group>
<article-title>Detoxification of patulin and ochratoxin A, two abundant mycotoxins, by lactic acid bacteria</article-title>. <source>Food Chem Toxicol</source>
<year>2008</year>;<volume>46</volume>:<fpage>1398</fpage>&#x02013;<lpage>407</lpage>.<pub-id pub-id-type="pmid">18061329</pub-id></mixed-citation></ref><ref id="C12"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aureli</surname><given-names>P</given-names></name>, <name><surname>Capurso</surname><given-names>L</given-names></name>, <name><surname>Castellazzi</surname><given-names>AM</given-names></name>, <name><surname>Clerici</surname><given-names>M</given-names></name>, <name><surname>Giovannini</surname><given-names>M</given-names></name>, <name><surname>Morelli</surname><given-names>L</given-names></name>, <etal><italic>et al.</italic></etal></person-group>
<article-title>Probiotics and health: An evidence-based review</article-title>. <source>Pharmacol Res</source>
<year>2011</year>;<volume>63</volume>:<fpage>366</fpage>&#x02013;<lpage>76</lpage>.<pub-id pub-id-type="pmid">21349334</pub-id></mixed-citation></ref><ref id="C13"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weber</surname><given-names>TK</given-names></name>, <name><surname>Polanco</surname><given-names>I</given-names></name></person-group>
<article-title>Gastrointestinal microbiota and some children diseases: a review</article-title>. <source>Gastroenterol Res Pract.</source>
<year>2012</year>;<comment>2012:676585</comment>.</mixed-citation></ref><ref id="C14"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O'Hara</surname><given-names>A</given-names></name>, <name><surname>O'Regan</surname><given-names>P</given-names></name>, <name><surname>Fanning</surname><given-names>A</given-names></name>, <name><surname>O'Mahony</surname><given-names>C</given-names></name>, <name><surname>MacSharry</surname><given-names>J</given-names></name>, <name><surname>Lyons</surname><given-names>A</given-names></name></person-group>
<article-title>Functional modulation of human intestinal epithelial cell responses by <italic>Bifidobacterium infantis</italic> and <italic>Lactobacillus salivarius</italic></article-title>. <source>Immunology</source>
<year>2006</year>;<volume>118</volume>:<fpage>202</fpage>&#x02013;<lpage>15</lpage>.<pub-id pub-id-type="pmid">16771855</pub-id></mixed-citation></ref><ref id="C15"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turroni</surname><given-names>F</given-names></name>, <name><surname>Ribbera</surname><given-names>A</given-names></name>, <name><surname>Foroni</surname><given-names>E</given-names></name>, <name><surname>van Sinderen</surname><given-names>D</given-names></name>, <name><surname>Ventura</surname><given-names>M</given-names></name></person-group>
<article-title>Human gut microbiota and Bifidobacteria: from composition to functionality</article-title>. <source>Antonie van Leeuwenhoek</source>
<year>2008</year>;<volume>94</volume>:<fpage>35</fpage>&#x02013;<lpage>50</lpage>.<pub-id pub-id-type="pmid">18338233</pub-id></mixed-citation></ref><ref id="C16"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El-Ansary</surname><given-names>A</given-names></name>, <name><surname>Shaker</surname><given-names>GH</given-names></name>, <name><surname>Rizk</surname><given-names>MZ</given-names></name></person-group>
<article-title>Role of gut&#x02013;brain axis in the etiology of neurodevelopmental disorders with reference to autism</article-title>. <source>J Clin Toxicol</source>
<year>2013</year>;<volume>S6</volume>:<fpage>1</fpage>&#x02013;<lpage>8</lpage>.</mixed-citation></ref><ref id="C17"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arunachalam</surname><given-names>K</given-names></name>, <name><surname>Gill</surname><given-names>HS</given-names></name>, <name><surname>Chandra</surname><given-names>RK</given-names></name></person-group>
<article-title>Enhancement of natural immune function by dietary consumption of <italic>Bifidobacterium lactis</italic> (HN019)</article-title>. <source>Eur J Clin Nutr</source>
<year>2000</year>;<volume>54</volume>:<fpage>263</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="pmid">10713750</pub-id></mixed-citation></ref><ref id="C18"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uehara</surname><given-names>Y</given-names></name>, <name><surname>Kikuchi</surname><given-names>K</given-names></name>, <name><surname>Nakamura</surname><given-names>T</given-names></name>, <name><surname>Nakama</surname><given-names>H</given-names></name>, <name><surname>Agematsu</surname><given-names>K</given-names></name>, <name><surname>Kawakami</surname><given-names>Y</given-names></name>, <etal><italic>et al.</italic></etal></person-group>
<article-title>Inhibition of methicillin-resistant <italic>Staphylococcus aureus</italic> colonization of oral cavities in newborns by Viridans group Streptococci</article-title>. <source>Clin Infect Dis</source>
<year>2001</year>;<volume>32</volume>:<fpage>1399</fpage>&#x02013;<lpage>407</lpage>.<pub-id pub-id-type="pmid">11317239</pub-id></mixed-citation></ref><ref id="C19"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Noverr</surname><given-names>M</given-names></name>, <name><surname>Huffnagle</surname><given-names>GB</given-names></name></person-group>
<article-title>Does the microbiota regulate immune responses outside the gut?</article-title>
<source>Trends Microbiol</source>
<year>2004</year>;<volume>12</volume>(<issue>12</issue>):<fpage>562</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">15539116</pub-id></mixed-citation></ref><ref id="C20"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>B&#x000f6;hmig</surname><given-names>GA</given-names></name>, <name><surname>Krieger</surname><given-names>PM</given-names></name>, <name><surname>S&#x000e4;emann</surname><given-names>MD</given-names></name>, <name><surname>Wenhardt</surname><given-names>C</given-names></name>, <name><surname>Pohanka</surname><given-names>E</given-names></name>, <name><surname>Zlabinger</surname><given-names>GJ</given-names></name></person-group>
<article-title>n-Butyrate downregulates the stimulatory function of peripheral blood-derived antigen-presenting cells: a potential mechanism for modulating T-cell responses by short-chain fatty acids</article-title>. <source>Immunology</source>
<year>1997</year>;<volume>92</volume>(<issue>2</issue>):<fpage>234</fpage>&#x02013;<lpage>43</lpage>.<pub-id pub-id-type="pmid">9415032</pub-id></mixed-citation></ref><ref id="C21"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wagner</surname><given-names>RD</given-names></name>, <name><surname>Pierson</surname><given-names>C</given-names></name>, <name><surname>Warner</surname><given-names>T</given-names></name>, <name><surname>Dohnalek</surname><given-names>M</given-names></name>, <name><surname>Farmer</surname><given-names>J</given-names></name>, <name><surname>Roberts</surname><given-names>L</given-names></name>, <etal><italic>et al.</italic></etal></person-group>
<article-title>Biotherapeutic effects of probiotic bacteria on candidiasis in immunodeficient mice</article-title>. <source>Infect Immun</source>
<year>1997</year>;<volume>65</volume>(<issue>10</issue>):<fpage>4165</fpage>&#x02013;<lpage>72</lpage>.<pub-id pub-id-type="pmid">9317023</pub-id></mixed-citation></ref><ref id="C22"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Finegold</surname><given-names>SM</given-names></name>, <name><surname>Dowd</surname><given-names>SE</given-names></name>, <name><surname>Gontcharova</surname><given-names>V</given-names></name>, <name><surname>Liu</surname><given-names>C</given-names></name>, <name><surname>Henley</surname><given-names>KE</given-names></name>, <name><surname>Wolcott</surname><given-names>RD</given-names></name>, <etal><italic>et al.</italic></etal></person-group>
<article-title>Pyrosequencing study of fecal microflora of autistic and control children</article-title>. <source>Anaerobe</source>
<year>2010</year>;<volume>16</volume>:<fpage>444</fpage>&#x02013;<lpage>53</lpage>.<pub-id pub-id-type="pmid">20603222</pub-id></mixed-citation></ref><ref id="C23"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>Y</given-names></name>, <name><surname>Liu</surname><given-names>C</given-names></name>, <name><surname>Finegold</surname><given-names>SM</given-names></name></person-group>
<article-title>Real-time PCR quantitation of <italic>Clostridia</italic> in feces of autistic children</article-title>. <source>Appl Environ Microbiol</source>
<year>2004</year>;<volume>70</volume>(<issue>11</issue>):<fpage>6459</fpage>&#x02013;<lpage>65</lpage>.<pub-id pub-id-type="pmid">15528506</pub-id></mixed-citation></ref><ref id="C24"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gondalia</surname><given-names>SV</given-names></name>, <name><surname>Palombo</surname><given-names>EA</given-names></name>, <name><surname>Knowles</surname><given-names>SR</given-names></name>, <name><surname>Cox</surname><given-names>SB</given-names></name>, <name><surname>Meyer</surname><given-names>D</given-names></name>, <name><surname>Austin</surname><given-names>DW</given-names></name></person-group>
<article-title>Molecular characterization of gastrointestinal microbiota of children (with and without gastrointestinal dysfunction) and their neurotypical siblings</article-title>. <source>Autism Res</source>
<year>2012</year>;<volume>5</volume>(<issue>6</issue>):<fpage>419</fpage>&#x02013;<lpage>27</lpage>.<pub-id pub-id-type="pmid">22997101</pub-id></mixed-citation></ref><ref id="C25"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parracho</surname><given-names>HM</given-names></name>, <name><surname>Bingham</surname><given-names>MO</given-names></name>, <name><surname>Gibson</surname><given-names>GR</given-names></name>, <name><surname>McCartney</surname><given-names>AL</given-names></name></person-group>
<article-title>Differences between the gut microflora of children with autistic spectrum disorders and that of healthy children</article-title>. <source>J Med Microbiol</source>
<year>2005</year>;<volume>54</volume>:<fpage>987</fpage>&#x02013;<lpage>91</lpage>.<pub-id pub-id-type="pmid">16157555</pub-id></mixed-citation></ref><ref id="C26"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Finegold</surname><given-names>SM</given-names></name></person-group>
<article-title>State of the art; microbiology in health and disease. Intestinal bacterial flora in autism</article-title>. <source>Anaerobe</source>
<year>2011</year>;<volume>17</volume>:<fpage>367</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">21524713</pub-id></mixed-citation></ref><ref id="C27"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Finegold</surname><given-names>SM</given-names></name>, <name><surname>Downes</surname><given-names>J</given-names></name>, <name><surname>Summanen</surname><given-names>PH</given-names></name></person-group>
<article-title>Microbiology of regressive autism</article-title>. <source>Anaerobe</source>
<year>2012</year>;<volume>18</volume>:<fpage>260</fpage>&#x02013;<lpage>2</lpage>.<pub-id pub-id-type="pmid">22202440</pub-id></mixed-citation></ref><ref id="C28"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname><given-names>CJ</given-names></name>, <name><surname>Bohannan</surname><given-names>BJ</given-names></name>, <name><surname>Young</surname><given-names>VB</given-names></name></person-group>
<article-title>From structure to function: the ecology of host-associated microbial communities</article-title>. <source>Microbiol Mol Biol Rev</source>
<year>2010</year>;<volume>74</volume>:<fpage>453</fpage>&#x02013;<lpage>76</lpage>.<pub-id pub-id-type="pmid">20805407</pub-id></mixed-citation></ref><ref id="C29"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Finegold</surname><given-names>SM</given-names></name></person-group>
<article-title>Therapy and epidemiology of autism-clostridial spores as key elements</article-title>. <source>Med Hypotheses</source>
<year>2008</year>;<volume>70</volume>:<fpage>508</fpage>&#x02013;<lpage>11</lpage>.<pub-id pub-id-type="pmid">17904761</pub-id></mixed-citation></ref><ref id="C30"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname><given-names>DW</given-names></name>, <name><surname>Park</surname><given-names>JG</given-names></name>, <name><surname>Ilhan</surname><given-names>ZE</given-names></name>, <name><surname>Wallstrom</surname><given-names>G</given-names></name>, <name><surname>LaBaer</surname><given-names>J</given-names></name>, <name><surname>Adams</surname><given-names>JB</given-names></name>, <etal><italic>et al.</italic></etal></person-group>
<article-title>Reduced incidence of <italic>Prevotella</italic> and other fermenters in intestinal microflora of autistic children</article-title>. <source>PLoS ONE</source>
<year>2013</year>;<volume>8</volume>:<fpage>e68322</fpage>.<pub-id pub-id-type="pmid">23844187</pub-id></mixed-citation></ref><ref id="C31"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lonsdale</surname><given-names>D</given-names></name>, <name><surname>Shamberger</surname><given-names>RJ</given-names></name>, <name><surname>Aduya</surname><given-names>T</given-names></name></person-group>
<article-title>Treatment of autism spectrum children with thiamine tetrahydrofurfuryl disulfide: a pilot study</article-title>. <source>Neuro Endocrinol Lett</source>
<year>2002</year>;<volume>23</volume>:<fpage>303</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">12195231</pub-id></mixed-citation></ref><ref id="C32"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arumugan</surname><given-names>M</given-names></name>, <name><surname>Raes</surname><given-names>J</given-names></name>, <name><surname>Pellettier</surname><given-names>E</given-names></name>, <name><surname>Le Paslier</surname><given-names>D</given-names></name>, <name><surname>Yamada</surname><given-names>T</given-names></name>, <name><surname>Mende</surname><given-names>DR</given-names></name>, <etal><italic>et al.</italic></etal></person-group>
<article-title>Enterotypes of human gut microbiome</article-title>. <source>Nature</source>
<year>2011</year>;<volume>473</volume>:<fpage>174</fpage>&#x02013;<lpage>80</lpage>.<pub-id pub-id-type="pmid">21508958</pub-id></mixed-citation></ref><ref id="C33"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yatsunenko</surname><given-names>T</given-names></name>, <name><surname>Rey</surname><given-names>FE</given-names></name>, <name><surname>Manary</surname><given-names>MJ</given-names></name>, <name><surname>Trehan</surname><given-names>I</given-names></name>, <name><surname>Dominguez-Bello</surname><given-names>MG</given-names></name>, <etal><italic>et al.</italic></etal></person-group>
<article-title>Human gut microbiome viewed across age and geography</article-title>. <source>Nature</source>
<year>2012</year>;<volume>486</volume>:<fpage>222</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="pmid">22699611</pub-id></mixed-citation></ref><ref id="C34"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baquero</surname><given-names>F</given-names></name>, <name><surname>Nombela</surname><given-names>C</given-names></name></person-group>
<article-title>The microbiome as human organ</article-title>. <source>Clin Microbiol Infect</source>
<year>2012</year>;<volume>18</volume>(<issue>S4</issue>):<fpage>2</fpage>&#x02013;<lpage>4</lpage>.<pub-id pub-id-type="pmid">22647038</pub-id></mixed-citation></ref><ref id="C35"><label>35</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>MacFabe</surname><given-names>DF</given-names></name>, <name><surname>Cain</surname><given-names>NE</given-names></name>, <name><surname>Boon</surname><given-names>F</given-names></name>, <name><surname>Ossenkopp</surname><given-names>KP</given-names></name>, <name><surname>Cain</surname><given-names>DP</given-names></name></person-group>
<article-title>Effects of the enteric bacterial metabolic product propionic acid on object-directed behavior, social behavior, cognition and neuro inflammation in adolescent rats: relevance to autism spectrum disorder</article-title>. <source>Behav Brain Res</source>
<year>2011</year>;<volume>217</volume>:<fpage>47</fpage>&#x02013;<lpage>54</lpage>.<pub-id pub-id-type="pmid">20937326</pub-id></mixed-citation></ref><ref id="C36"><label>36</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fry</surname><given-names>RE</given-names></name>, <name><surname>MacFabe</surname><given-names>DF</given-names></name></person-group>
<article-title>Unique acyl-carnitine profiles are potential biomarkers for acquired mitochondrial disease in autism spectrum disorder</article-title>. <source>Transl Psychiatry</source>
<year>2013</year>;<volume>3</volume>:<fpage>e220</fpage>.<pub-id pub-id-type="pmid">23340503</pub-id></mixed-citation></ref><ref id="C37"><label>37</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shaw</surname><given-names>W</given-names></name>, <name><surname>Kassen</surname><given-names>E</given-names></name>, <name><surname>Chaves</surname><given-names>E</given-names></name></person-group>
<article-title>Increased urinary excretion of analogs of Krebs cycle metabolites and arabinose in two brothers with autistic features</article-title>. <source>Clin Chem</source>
<year>1995</year>;<volume>41</volume>:<fpage>1094</fpage>&#x02013;<lpage>104</lpage>.<pub-id pub-id-type="pmid">7628083</pub-id></mixed-citation></ref><ref id="C38"><label>38</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shaw</surname><given-names>W</given-names></name>, <name><surname>Kassen</surname><given-names>E</given-names></name>, <name><surname>Chaves</surname><given-names>E</given-names></name></person-group>
<article-title>Assessment of antifungal drug therapy in autism by measurement of suspected microbial metabolites in urine with gas chromatography-mass spectrometry</article-title>. <source>Clin Pract Alter Med</source>
<year>2000</year>;<volume>1</volume>:<fpage>15</fpage>&#x02013;<lpage>26</lpage>.</mixed-citation></ref><ref id="C39"><label>39</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kalu&#x0017c;na-Czapli&#x00144;ska</surname><given-names>J</given-names></name>, <name><surname>B&#x00142;aszczyk</surname><given-names>S</given-names></name></person-group>
<article-title>The level of arabinitol in autistic children after probiotic therapy</article-title>. <source>Nutrition</source>
<year>2012</year>;<volume>28</volume>(<issue>2</issue>):<fpage>124</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="pmid">22079796</pub-id></mixed-citation></ref><ref id="C40"><label>40</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Finegold</surname><given-names>SM</given-names></name>, <name><surname>Molitoris</surname><given-names>D</given-names></name>, <name><surname>Song</surname><given-names>Y</given-names></name>, <name><surname>Liu</surname><given-names>C</given-names></name>, <name><surname>Vaisanen</surname><given-names>ML</given-names></name>, <name><surname>Bolte</surname><given-names>E</given-names></name>, <etal><italic>et al.</italic></etal></person-group>
<article-title>Gastrointestinal microflora studies in late-onset autism</article-title>. <source>Clin Infect Dis</source>
<year>2002</year>;<volume>35</volume><issue>Suppl 1</issue>:<fpage>S6</fpage>&#x02013;<lpage>S16</lpage>.<pub-id pub-id-type="pmid">12173102</pub-id></mixed-citation></ref><ref id="C41"><label>41</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kidd</surname><given-names>PM</given-names></name></person-group>
<article-title>Autism, an extreme challenge to integrative medicine. Part 2: medical management</article-title>. <source>Altern Med Rev</source>
<year>2002</year>;<volume>7</volume>:<fpage>472</fpage>&#x02013;<lpage>99</lpage>.<pub-id pub-id-type="pmid">12495373</pub-id></mixed-citation></ref><ref id="C42"><label>42</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>BL</given-names></name>, <name><surname>Hornig</surname><given-names>M</given-names></name>, <name><surname>Buie</surname><given-names>T</given-names></name>, <name><surname>Bauman</surname><given-names>ML</given-names></name>, <name><surname>Cho Paik</surname><given-names>M</given-names></name>, <name><surname>Wick</surname><given-names>I</given-names></name>, <etal><italic>et al.</italic></etal></person-group>
<article-title>Impaired carbohydrate digestion and transport and mucosal dysbiosis in the intestines of children with autism and gastrointestinal disturbances</article-title>. <source>PLoS ONE</source>
<year>2011</year>;<volume>6</volume>:<fpage>e24585</fpage>.<pub-id pub-id-type="pmid">21949732</pub-id></mixed-citation></ref><ref id="C43"><label>43</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Magistris</surname><given-names>L</given-names></name>, <name><surname>Familiari</surname><given-names>V</given-names></name>, <name><surname>Pascotto</surname><given-names>A</given-names></name>, <name><surname>Sapone</surname><given-names>A</given-names></name>, <name><surname>Frolli</surname><given-names>A</given-names></name>, <name><surname>Iardino</surname><given-names>P</given-names></name>, <etal><italic>et al.</italic></etal></person-group>
<article-title>Alterations of the intestinal barrier in patients with autism spectrum disorders and in their first-degree relatives</article-title>. <source>J Pediatr Gastroenterol Nutr</source>
<year>2010</year>;<volume>51</volume>:<fpage>418</fpage>&#x02013;<lpage>24</lpage>.<pub-id pub-id-type="pmid">20683204</pub-id></mixed-citation></ref><ref id="C44"><label>44</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prakash</surname><given-names>S</given-names></name>, <name><surname>Tomaro-Duchesneau</surname><given-names>C</given-names></name>, <name><surname>Saha</surname><given-names>S</given-names></name>, <name><surname>Cantor</surname><given-names>A</given-names></name></person-group>
<article-title>The gut microbiota and human health with an emphasis on the use of microencapsulated bacterial cells</article-title>. <source>J Biomed Biotechnol</source>
<year>2011</year>;<comment>Article ID 981214</comment>.</mixed-citation></ref><ref id="C45"><label>45</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koenig</surname><given-names>JE</given-names></name>, <name><surname>Spor</surname><given-names>A</given-names></name>, <name><surname>Scalfone</surname><given-names>N</given-names></name>, <name><surname>Fricker</surname><given-names>AD</given-names></name>, <name><surname>Stombaugh</surname><given-names>J</given-names></name>, <name><surname>Knight</surname><given-names>R</given-names></name>, <etal><italic>et al.</italic></etal></person-group>
<article-title>Succession of microbial consortia in the developing infant gut microbiome</article-title>. <source>Proc Natl Acad Sci USA</source>
<year>2011</year>;<volume>108</volume><issue>Suppl 1</issue>:<fpage>4578</fpage>&#x02013;<lpage>85</lpage>.<pub-id pub-id-type="pmid">20668239</pub-id></mixed-citation></ref><ref id="C46"><label>46</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eriksson</surname><given-names>MA</given-names></name>, <name><surname>Westerlund</surname><given-names>J</given-names></name>, <name><surname>Anderlid</surname><given-names>BM</given-names></name>, <name><surname>Gillberg</surname><given-names>C</given-names></name>, <name><surname>Fernell</surname><given-names>E</given-names></name></person-group>
<article-title>First-degree relatives of young children with autism spectrum disorders: some gender aspects</article-title>. <source>Res Dev Disabil</source>
<year>2012</year>;<volume>33</volume>:<fpage>1642</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">22554810</pub-id></mixed-citation></ref><ref id="C47"><label>47</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mulle</surname><given-names>JG</given-names></name>, <name><surname>Sharp</surname><given-names>WG</given-names></name>, <name><surname>Cubells</surname><given-names>JF</given-names></name></person-group>
<article-title>The gut microbiome: a new frontier in autism research</article-title>. <source>Curr Psychiatr Rep</source>
<year>2013</year>;<volume>15</volume>(<issue>2</issue>):<fpage>337</fpage>.</mixed-citation></ref><ref id="C48"><label>48</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adlerberth</surname><given-names>I</given-names></name>, <name><surname>Wold</surname><given-names>AE</given-names></name></person-group>
<article-title>Establishment of the gut microbiota in Western infants</article-title>. <source>Acta Pediatr</source>
<year>2009</year>;<volume>98</volume>:<fpage>229</fpage>&#x02013;<lpage>38</lpage>.</mixed-citation></ref><ref id="C49"><label>49</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dominguez-Bello</surname><given-names>MG</given-names></name>, <name><surname>Costello</surname><given-names>EK</given-names></name>, <name><surname>Contreras</surname><given-names>M</given-names></name>, <name><surname>Magris</surname><given-names>M</given-names></name>, <name><surname>Hidalgo</surname><given-names>G</given-names></name>, <name><surname>Fierer</surname><given-names>N</given-names></name>, <etal><italic>et al.</italic></etal></person-group>
<article-title>Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns</article-title>. <source>Proc Natl Acad Sci USA</source>
<year>2010</year>;<volume>107</volume>(<issue>26</issue>):<fpage>11971</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="pmid">20566857</pub-id></mixed-citation></ref><ref id="C50"><label>50</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clemente</surname><given-names>JC</given-names></name>, <name><surname>Ursell</surname><given-names>LK</given-names></name>, <name><surname>Wegener Parfrey</surname><given-names>L</given-names></name>, <name><surname>Knight</surname><given-names>R</given-names></name></person-group>
<article-title>The impact of gut microbiota on human health: an integrative view</article-title>. <source>Cell</source>
<year>2013</year>;<volume>148</volume>:<fpage>1258</fpage>&#x02013;<lpage>70</lpage>.<pub-id pub-id-type="pmid">22424233</pub-id></mixed-citation></ref><ref id="C51"><label>51</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neu</surname><given-names>J</given-names></name>, <name><surname>Walker</surname><given-names>WA</given-names></name></person-group>
<article-title>Necrotizing enterocolitis</article-title>. <source>N Engl J Med</source>
<year>2011</year>;<volume>364</volume>(<issue>3</issue>):<fpage>225</fpage>&#x02013;<lpage>64</lpage>.</mixed-citation></ref><ref id="C52"><label>52</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meldrum</surname><given-names>SJ</given-names></name>, <name><surname>Strunk</surname><given-names>T</given-names></name>, <name><surname>Currie</surname><given-names>A</given-names></name>, <name><surname>Prescott</surname><given-names>SL</given-names></name>, <name><surname>Simmer</surname><given-names>K</given-names></name>, <name><surname>Whitehoue</surname><given-names>AJO</given-names></name></person-group>
<article-title>Autism spectrum disorder in children born preterm-role of exposure to perinatal inflammation</article-title>. <source>Front Neurosci</source>
<year>2013</year>;<volume>7</volume>:<fpage>1</fpage>&#x02013;<lpage>10</lpage>.<pub-id pub-id-type="pmid">23386807</pub-id></mixed-citation></ref><ref id="C53"><label>53</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palmer</surname><given-names>C</given-names></name>, <name><surname>Bik</surname><given-names>EM</given-names></name>, <name><surname>DiGiulio</surname><given-names>DB</given-names></name>, <name><surname>Relman</surname><given-names>DA</given-names></name>, <name><surname>Brown</surname><given-names>PO</given-names></name></person-group>
<article-title>Development of the human infant intestinal microbiota</article-title>. <source>PLoS Biol</source>
<year>2007</year>;<volume>5</volume>:<fpage>e177</fpage>.<pub-id pub-id-type="pmid">17594176</pub-id></mixed-citation></ref><ref id="C54"><label>54</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Newburg</surname><given-names>DS</given-names></name></person-group>
<article-title>Neonatal protection by innate immune system of human milk consisting of oligosaccharides and glycans</article-title>. <source>J Anim Sci</source>
<year>2009</year>;<volume>87</volume>:<fpage>26</fpage>&#x02013;<lpage>34</lpage>.<pub-id pub-id-type="pmid">19028867</pub-id></mixed-citation></ref><ref id="C55"><label>55</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perez</surname><given-names>PF</given-names></name>, <name><surname>Dor&#x000e8;</surname><given-names>J</given-names></name>, <name><surname>Leclerc</surname><given-names>M</given-names></name>, <name><surname>Levenez</surname><given-names>F</given-names></name>, <name><surname>Benyacoub</surname><given-names>J</given-names></name>, <name><surname>Serrant</surname><given-names>P</given-names></name>, <etal><italic>et al.</italic></etal></person-group>
<article-title>Bacterial imprinting of neonatal immune system: a lesson from maternal cells?</article-title>
<source>Pediatrics</source>
<year>2007</year>;<volume>119</volume>:<fpage>e724</fpage>&#x02013;<lpage>32</lpage>.<pub-id pub-id-type="pmid">17332189</pub-id></mixed-citation></ref><ref id="C56"><label>56</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hunt</surname><given-names>KM</given-names></name>, <name><surname>Foster</surname><given-names>JA</given-names></name>, <name><surname>Forney</surname><given-names>LJ</given-names></name>, <name><surname>Sch&#x000fc;tte</surname><given-names>UM</given-names></name>, <name><surname>Beck</surname><given-names>DL</given-names></name>, <name><surname>Abdo</surname><given-names>Z</given-names></name>, <etal><italic>et al.</italic></etal></person-group>
<article-title>Characterization of the diversity and temporal stability of bacterial communities in human milk</article-title>. <source>PLoS ONE</source>
<year>2011</year>;<volume>6</volume>(<issue>6</issue>):<fpage>e21313</fpage>.<pub-id pub-id-type="pmid">21695057</pub-id></mixed-citation></ref><ref id="C57"><label>57</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zinkernagel</surname><given-names>RM</given-names></name></person-group>
<article-title>Maternal antibodies, childhood infections, and autoimmune diseases</article-title>. <source>N Engl J Med</source>
<year>2001</year>;<volume>345</volume>:<fpage>1331</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="pmid">11794153</pub-id></mixed-citation></ref><ref id="C58"><label>58</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lainhart</surname><given-names>JE</given-names></name>, <name><surname>Ozonoff</surname><given-names>S</given-names></name>, <name><surname>Coon</surname><given-names>H</given-names></name>, <name><surname>Krasny</surname><given-names>L</given-names></name>, <name><surname>Dinh</surname><given-names>E</given-names></name>, <name><surname>Nice</surname><given-names>J</given-names></name>, <etal><italic>et al.</italic></etal></person-group>
<article-title>Autism, regression, and the broader autism phenotype</article-title>. <source>Am J Med Genet</source>
<year>2002</year>;<volume>113</volume>:<fpage>231</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="pmid">12439889</pub-id></mixed-citation></ref><ref id="C59"><label>59</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Atlad&#x000f3;ttir</surname><given-names>HO</given-names></name>, <name><surname>Henriksen</surname><given-names>TB</given-names></name>, <name><surname>Schendel</surname><given-names>DE</given-names></name>, <name><surname>Parner</surname><given-names>ET</given-names></name></person-group>
<article-title>Autism after infection, febrile episodes, and antibiotic use during pregnancy: an exploratory study</article-title>. <source>Pediatrics</source>
<year>2012</year>;<volume>103</volume>(<issue>6</issue>):<fpage>e1447</fpage>&#x02013;<lpage>54</lpage>.<pub-id pub-id-type="pmid">23147969</pub-id></mixed-citation></ref><ref id="C60"><label>60</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tajima-Pozo</surname><given-names>K</given-names></name>, <name><surname>Zambrano-Enriquez</surname><given-names>D</given-names></name>, <name><surname>De Anta</surname><given-names>L</given-names></name>, <name><surname>Zelmanova</surname><given-names>J</given-names></name>, <name><surname>De Dios Vega</surname><given-names>JL</given-names></name>, <name><surname>Lopez-Ibor</surname><given-names>J</given-names></name></person-group>
<article-title>Otitis and autism spectrum disorders</article-title>. <source>BMJ Case Rep</source>
<year>2010</year>; <comment>2010: bcr10.2009.2351</comment>.</mixed-citation></ref><ref id="C61"><label>61</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Str&#x000f6;mland</surname><given-names>K</given-names></name>, <name><surname>Miller</surname><given-names>M</given-names></name>, <name><surname>Sj&#x000f6;green</surname><given-names>L</given-names></name>, <name><surname>Johansson</surname><given-names>M</given-names></name>, <name><surname>Joelsson</surname><given-names>BME</given-names></name>, <name><surname>Billstedt</surname><given-names>E</given-names></name>, <etal><italic>et al.</italic></etal></person-group>
<article-title>Oculo-auriculo vertebral spectrum: associated anomalies, functional deficits and possible developmental risk factors</article-title>. <source>Am J Med Genet</source>
<year>2007</year>;<volume>143A</volume>:<fpage>1317</fpage>&#x02013;<lpage>25</lpage>.<pub-id pub-id-type="pmid">17506093</pub-id></mixed-citation></ref><ref id="C62"><label>62</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dethlefsen</surname><given-names>L</given-names></name>, <name><surname>Huse</surname><given-names>S</given-names></name>, <name><surname>Sogin</surname><given-names>ML</given-names></name>, <name><surname>Relman</surname><given-names>DA</given-names></name></person-group>
<article-title>The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing</article-title>. <source>PLoS Biol</source>
<year>2008</year>;<volume>6</volume>(<issue>11</issue>):<fpage>e280</fpage>.<pub-id pub-id-type="pmid">19018661</pub-id></mixed-citation></ref><ref id="C63"><label>63</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jernberg</surname><given-names>C</given-names></name>, <name><surname>L&#x000f6;fmark</surname><given-names>S</given-names></name>, <name><surname>Edlund</surname><given-names>C</given-names></name>, <name><surname>Jansson</surname><given-names>JK</given-names></name></person-group>
<article-title>Long-term ecological impacts of antibiotic administration on the human intestinal microbiota</article-title>. <source>ISME J</source>
<year>2007</year>;<volume>1</volume>(<issue>1</issue>):<fpage>56</fpage>&#x02013;<lpage>66</lpage>.<pub-id pub-id-type="pmid">18043614</pub-id></mixed-citation></ref><ref id="C64"><label>64</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sullivan</surname><given-names>A</given-names></name>, <name><surname>Edlund</surname><given-names>C</given-names></name>, <name><surname>Nord</surname><given-names>CE</given-names></name></person-group>
<article-title>Effect of antimicrobial agents on the ecological balance of human microflora</article-title>. <source>Lancet Infect Dis</source>
<year>2001</year>;<volume>1</volume>(<issue>2</issue>):<fpage>101</fpage>&#x02013;<lpage>14</lpage>.<pub-id pub-id-type="pmid">11871461</pub-id></mixed-citation></ref><ref id="C65"><label>65</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sommer</surname><given-names>MO</given-names></name>, <name><surname>Dantas</surname><given-names>G</given-names></name>, <name><surname>Church</surname><given-names>GM</given-names></name></person-group>
<article-title>Functional characterization of the antibiotic resistance reservoir in the human microflora</article-title>. <source>Science</source>
<year>2009</year>;<volume>325</volume>(<issue>5944</issue>):<fpage>1128</fpage>&#x02013;<lpage>31</lpage>.<pub-id pub-id-type="pmid">19713526</pub-id></mixed-citation></ref><ref id="C66"><label>66</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fallon</surname><given-names>J</given-names></name></person-group>
<article-title>Could one of the most prescribed antibiotics amoxicillin/clavunalate &#x02018;augmentin&#x02019;&#x02122; be a risk factor for autism?</article-title>
<source>Med Hypotheses</source>
<year>2005</year>;<volume>64</volume>:<fpage>312</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="pmid">15607562</pub-id></mixed-citation></ref><ref id="C67"><label>67</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schrag</surname><given-names>S</given-names></name>, <name><surname>Zywicki</surname><given-names>S</given-names></name>, <name><surname>Farley</surname><given-names>M</given-names></name>, <name><surname>Reingold</surname><given-names>Al</given-names></name>, <name><surname>Harrison</surname><given-names>LH</given-names></name>, <name><surname>Lefkowitz</surname><given-names>LB</given-names></name>, <etal><italic>et al.</italic></etal></person-group>
<article-title>Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis</article-title>. <source>New Engl J Med</source>
<year>2000</year>;<volume>342</volume>:<fpage>15</fpage>&#x02013;<lpage>20</lpage>.<pub-id pub-id-type="pmid">10620644</pub-id></mixed-citation></ref><ref id="C68"><label>68</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reichelt</surname><given-names>KL</given-names></name>, <name><surname>Knivsberg</surname><given-names>AM</given-names></name></person-group>
<article-title>The possibility and probability of a gut-to-brain connection in autism</article-title>. <source>Ann Clin Psychiatry</source>
<year>2009</year>;<volume>21</volume>:<fpage>205</fpage>&#x02013;<lpage>11</lpage>.<pub-id pub-id-type="pmid">19917211</pub-id></mixed-citation></ref><ref id="C69"><label>69</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sandler</surname><given-names>RH</given-names></name>, <name><surname>Finegold</surname><given-names>SM</given-names></name>, <name><surname>Bolte</surname><given-names>ER</given-names></name>, <name><surname>Buchanan</surname><given-names>CP</given-names></name>, <name><surname>Maxwell</surname><given-names>AP</given-names></name>, <name><surname>Vaisanen</surname><given-names>ML</given-names></name>, <etal><italic>et al.</italic></etal></person-group>
<article-title>Short-term benefit from oral vancomycin treatment of regressive-onset autism</article-title>. <source>J Child Neurol</source>
<year>2000</year>;<volume>15</volume>:<fpage>429</fpage>&#x02013;<lpage>35</lpage>.<pub-id pub-id-type="pmid">10921511</pub-id></mixed-citation></ref><ref id="C70"><label>70</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Golnik</surname><given-names>AE</given-names></name>, <name><surname>Ireland</surname><given-names>M</given-names></name></person-group>
<article-title>Complementary alternative medicine for children with autism: a physician survey</article-title>. <source>J Autism Dev Disord</source>
<year>2009</year>;<volume>39</volume>:<fpage>996</fpage>&#x02013;<lpage>1005</lpage>.<pub-id pub-id-type="pmid">19280328</pub-id></mixed-citation></ref><ref id="C71"><label>71</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Critchfield</surname><given-names>JW</given-names></name>, <name><surname>van Hemert</surname><given-names>S</given-names></name>, <name><surname>Ash</surname><given-names>M</given-names></name>, <name><surname>Mulder</surname><given-names>L</given-names></name>, <name><surname>Ashwood</surname><given-names>P</given-names></name></person-group>
<article-title>The potential role of probiotics in the management of childhood autism spectrum disorders</article-title>. <source>Gastroenterol Res Pract</source>
<year>2011</year>;<volume>161358</volume>.</mixed-citation></ref><ref id="C72"><label>72</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bolte</surname><given-names>ER</given-names></name></person-group>
<article-title>Autism and <italic>Clostridium</italic> tetani</article-title>. <source>Med Hypotheses</source>
<year>1998</year>;<volume>51</volume>:<fpage>133</fpage>&#x02013;<lpage>44</lpage>.<pub-id pub-id-type="pmid">9881820</pub-id></mixed-citation></ref><ref id="C73"><label>73</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bebawy</surname><given-names>M</given-names></name>, <name><surname>Chetty</surname><given-names>M</given-names></name></person-group>
<article-title>Gender differences in p-glycoprotein expression and function: effects on drug disposition and outcome</article-title>. <source>Curr Drug Metab</source>
<year>2009</year>;<volume>10</volume>(<issue>4</issue>):<fpage>322</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">19519340</pub-id></mixed-citation></ref><ref id="C74"><label>74</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharp</surname><given-names>WG</given-names></name>, <name><surname>Jaquess</surname><given-names>DL</given-names></name>, <name><surname>Lukens</surname><given-names>CT</given-names></name></person-group>
<article-title>Multi-method assessment of feeding problems among children with autism spectrum disorders</article-title>. <source>Res Autism Spectr Disord</source>
<year>2013</year>;<volume>7</volume>:<fpage>56</fpage>&#x02013;<lpage>65</lpage>.</mixed-citation></ref><ref id="C75"><label>75</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Roshchina</surname><given-names>VV</given-names></name></person-group>
<article-title>Evolutionary considerations of neurotransmitters in microbial, plant, and animal cells</article-title>. In: <person-group person-group-type="editor"><name><surname>Lyte</surname><given-names>M</given-names></name></person-group>, (ed.). <source>Microbial endocrinology: Interkingdom signaling in infectious disease and health</source>. <edition>Freestone PPE editions</edition>
<publisher-loc>New York</publisher-loc>: <publisher-name>Springer</publisher-name>; <year>2010</year> p. <fpage>17</fpage>&#x02013;<lpage>52</lpage>.</mixed-citation></ref><ref id="C76"><label>76</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Norris</surname><given-names>V</given-names></name>, <name><surname>Molina</surname><given-names>F</given-names></name>, <name><surname>Gewirtz</surname><given-names>AT</given-names></name></person-group>
<article-title>Hypothesis: bacteria control host appetites</article-title>. <source>J Bacteriol</source>
<year>2013</year>;<volume>195</volume>(<issue>3</issue>):<fpage>411</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="pmid">23144247</pub-id></mixed-citation></ref><ref id="C77"><label>77</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lyte</surname><given-names>M</given-names></name></person-group>
<article-title>Microbial endocrinology and nutrition: a perspective on new mechanisms by which diet can influence gut-to-brain communication</article-title>. <source>Pharm Nutr</source>
<year>2013</year>;<volume>1</volume>:<fpage>35</fpage>&#x02013;<lpage>9</lpage>.</mixed-citation></ref><ref id="C78"><label>78</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>LeBlanc</surname><given-names>JJ</given-names></name>, <name><surname>Fagiolini</surname><given-names>M</given-names></name></person-group>
<article-title>Autism: a &#x02018;critical period&#x02019; disorder?</article-title>
<source>Neural Plast</source>
<year>2011</year>;<comment>2011:921680</comment>.</mixed-citation></ref><ref id="C79"><label>79</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bardin</surname><given-names>J</given-names></name></person-group>
<article-title>Unlocking the brain</article-title>. <source>Nature</source>
<year>2012</year>;<volume>487</volume>:<fpage>24</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="pmid">22763532</pub-id></mixed-citation></ref><ref id="C80"><label>80</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marco</surname><given-names>EJ</given-names></name>, <name><surname>Hinkley</surname><given-names>LBN</given-names></name>, <name><surname>Hill</surname><given-names>SS</given-names></name>, <name><surname>Nagarajan</surname><given-names>SS</given-names></name></person-group>
<article-title>Sensory processing in autism: a review of neurophysiologic findings</article-title>. <source>Pediatric Res</source>
<year>2011</year>;<volume>69</volume>:<fpage>48R</fpage>&#x02013;<lpage>54R</lpage>.</mixed-citation></ref><ref id="C81"><label>81</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simmons</surname><given-names>DR</given-names></name>, <name><surname>Robertson</surname><given-names>AE</given-names></name>, <name><surname>McKay</surname><given-names>LS</given-names></name>, <name><surname>Toal</surname><given-names>E</given-names></name>, <name><surname>McAleer</surname><given-names>P</given-names></name>, <name><surname>Pollick</surname><given-names>FE</given-names></name></person-group>
<article-title>Vision in autism spectrum disorders</article-title>. <source>Vis Res</source>
<year>2009</year>;<volume>49</volume>:<fpage>2705</fpage>&#x02013;<lpage>39</lpage>.<pub-id pub-id-type="pmid">19682485</pub-id></mixed-citation></ref><ref id="C82"><label>82</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fagiolini</surname><given-names>M</given-names></name>, <name><surname>Katagiri</surname><given-names>H</given-names></name>, <name><surname>Miyamoto</surname><given-names>H</given-names></name>, <name><surname>Mori</surname><given-names>H</given-names></name>, <name><surname>Grant</surname><given-names>SG</given-names></name>, <name><surname>Mishina</surname><given-names>M</given-names></name>, <etal><italic>et al.</italic></etal></person-group>
<article-title>Separable futures of visual cortical plasticity revealed by N-methyl-D-aspartate receptor 2A signaling</article-title>. <source>Proc Natl Acad Sci USA</source>
<year>2003</year>;<volume>100</volume>(<issue>5</issue>):<fpage>2854</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">12591944</pub-id></mixed-citation></ref><ref id="C83"><label>83</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fagiolini</surname><given-names>M</given-names></name>, <name><surname>Fritschy</surname><given-names>JM</given-names></name>, <name><surname>L&#x000f6;w</surname><given-names>K</given-names></name>, <name><surname>M&#x000f6;hler</surname><given-names>H</given-names></name>, <name><surname>Rudolph</surname><given-names>U</given-names></name>, <name><surname>Hensch</surname><given-names>TK</given-names></name></person-group>
<article-title>Specific GABBA circuits for visual cortical plasticity</article-title>. <source>Science</source>
<year>2004</year>;<volume>303</volume>:<fpage>1681</fpage>&#x02013;<lpage>3</lpage>.<pub-id pub-id-type="pmid">15017002</pub-id></mixed-citation></ref><ref id="C84"><label>84</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hensch</surname><given-names>TK</given-names></name>, <name><surname>Fagiolini</surname><given-names>M</given-names></name>, <name><surname>Mataga</surname><given-names>N</given-names></name>, <name><surname>Stryker</surname><given-names>MP</given-names></name>, <name><surname>Baekkeskov</surname><given-names>S</given-names></name>, <name><surname>Kash</surname><given-names>SF</given-names></name></person-group>
<article-title>Local GABBA circuit control of experience-dependent plasticity in developing visual cortex</article-title>. <source>Science</source>
<year>1998</year>;<volume>282</volume>:<fpage>1504</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">9822384</pub-id></mixed-citation></ref><ref id="C85"><label>85</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chao</surname><given-names>HT</given-names></name>, <name><surname>Chen</surname><given-names>H</given-names></name>, <name><surname>Samaco</surname><given-names>RC</given-names></name>, <name><surname>Xue</surname><given-names>M</given-names></name>, <name><surname>Chahrour</surname><given-names>M</given-names></name>, <etal><italic>et al.</italic></etal></person-group>
<article-title>Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes</article-title>. <source>Nature</source>
<year>2010</year>;<volume>468</volume>:<fpage>263</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">21068835</pub-id></mixed-citation></ref><ref id="C86"><label>86</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonzalez</surname><given-names>A</given-names></name>, <name><surname>Stombaugh</surname><given-names>J</given-names></name>, <name><surname>Lozupone</surname><given-names>C</given-names></name>, <name><surname>Turnbaugh</surname><given-names>PJ</given-names></name>, <name><surname>Gordon</surname><given-names>JI</given-names></name>, <name><surname>Knight</surname><given-names>R</given-names></name></person-group>
<article-title>The mind-body-microbial continuum</article-title>. <source>Dialogues Clin Neurosci</source>
<year>2011</year>;<volume>13</volume>:<fpage>55</fpage>&#x02013;<lpage>62</lpage>.<pub-id pub-id-type="pmid">21485746</pub-id></mixed-citation></ref><ref id="C87"><label>87</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonzalez-Ferero</surname><given-names>D</given-names></name>, <name><surname>Morcuende</surname><given-names>S</given-names></name>, <name><surname>Alvarez</surname><given-names>FJ</given-names></name>, <name><surname>de la Cruz</surname><given-names>RR</given-names></name>, <name><surname>Pastor</surname><given-names>AM</given-names></name></person-group>
<article-title>Transynaptic effects of tetanus neurotoxin in the oculomotor system</article-title>. <source>Brain</source>
<year>2005</year>;<volume>128</volume>:<fpage>2175</fpage>&#x02013;<lpage>88</lpage>.<pub-id pub-id-type="pmid">15987757</pub-id></mixed-citation></ref><ref id="C88"><label>88</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Banks</surname><given-names>WA</given-names></name>, <name><surname>Erickson</surname><given-names>MA</given-names></name></person-group>
<article-title>The blood-brain barrier and immune function and dysfunction</article-title>. <source>Neurobiol Dis</source>
<year>2010</year>;<volume>37</volume>:<fpage>26</fpage>&#x02013;<lpage>32</lpage>.<pub-id pub-id-type="pmid">19664708</pub-id></mixed-citation></ref><ref id="C89"><label>89</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bengmark</surname><given-names>S</given-names></name></person-group>
<article-title>Gut microbiota, immune development and function</article-title>. <source>Pharmacol Res</source>
<year>2013</year>;<volume>69</volume>:<fpage>87</fpage>&#x02013;<lpage>113</lpage>.<pub-id pub-id-type="pmid">22989504</pub-id></mixed-citation></ref><ref id="C90"><label>90</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuwabara</surname><given-names>H</given-names></name>, <name><surname>Yamasue</surname><given-names>H</given-names></name>, <name><surname>Koike</surname><given-names>S</given-names></name>, <name><surname>Inoue</surname><given-names>H</given-names></name>, <name><surname>Kawakubo</surname><given-names>Y</given-names></name>, <name><surname>Kuroda</surname><given-names>M</given-names></name>, <etal><italic>et al.</italic></etal></person-group>
<article-title>Altered metabolites in the plasma of autism spectrum disorder: a capillary electrophoresis time of flight mass spectroscopy study</article-title>. <source>PLoS ONE</source>
<year>2013</year>;<volume>8</volume>(<issue>9</issue>):<fpage>e73814</fpage>.<pub-id pub-id-type="pmid">24058493</pub-id></mixed-citation></ref><ref id="C91"><label>91</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Louis</surname><given-names>P</given-names></name></person-group>
<article-title>Does the human gut microbiota contribute to the etiology of autism spectrum disorders?</article-title>
<source>Dig Dis Sci</source>
<year>2012</year>;<volume>57</volume>:<fpage>1987</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">22736019</pub-id></mixed-citation></ref><ref id="C92"><label>92</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shaw</surname><given-names>W</given-names></name></person-group>
<article-title>Increased urinary excretion of a 3-(3-hydroxyphenyl)-3-hydroxypropionic acid (HPHPA), an abnormal phenylalanine metabolite of <italic>Clostridia</italic> spp. in the gastrointestinal tract, in urine samples from patients with autism and schizophrenia</article-title>. <source>Nutr Neurosci</source>
<year>2010</year>;<volume>13</volume>:<fpage>135</fpage>&#x02013;<lpage>43</lpage>.<pub-id pub-id-type="pmid">20423563</pub-id></mixed-citation></ref><ref id="C93"><label>93</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ming</surname><given-names>X</given-names></name>, <name><surname>Stein</surname><given-names>TP</given-names></name>, <name><surname>Barnes</surname><given-names>V</given-names></name>, <name><surname>Rhodes</surname><given-names>N</given-names></name>, <name><surname>Guo</surname><given-names>L</given-names></name></person-group>
<article-title>Metabolic perturbance in autism spectrum disorders: a metabolomics study</article-title>. <source>J Proteome</source>
<year>2012</year>;<volume>11</volume>:<fpage>5856</fpage>&#x02013;<lpage>62</lpage>.</mixed-citation></ref><ref id="C94"><label>94</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mavel</surname><given-names>S</given-names></name>, <name><surname>Nadal-Desbarats</surname><given-names>L</given-names></name>, <name><surname>Blasco</surname><given-names>H</given-names></name>, <name><surname>Bonnet-Brilhault</surname><given-names>F</given-names></name>, <name><surname>Barthelemy</surname><given-names>C</given-names></name>, <name><surname>Montigny</surname><given-names>F</given-names></name>, <etal><italic>et al.</italic></etal></person-group>
<article-title><sup>1</sup>H-<sup>13</sup>C NMR-based urine metabolic profiling in autism spectrum disorders</article-title>. <source>Talanta</source>
<year>2013</year>;<volume>95&#x02013;102</volume>.</mixed-citation></ref><ref id="C95"><label>95</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scharf</surname><given-names>DH</given-names></name>, <name><surname>Heinekamp</surname><given-names>T</given-names></name>, <name><surname>Remme</surname><given-names>N</given-names></name>, <name><surname>Hortschansky</surname><given-names>P</given-names></name>, <name><surname>Brakhage</surname><given-names>AA</given-names></name>, <name><surname>Hertweck</surname><given-names>C</given-names></name></person-group>
<article-title>Biosynthesis and function of gliotoxin in <italic>Aspergillus fumigatus</italic></article-title>. <source>Appl Microbiol Biotechnol</source>
<year>2012</year>;<volume>93</volume>:<fpage>467</fpage>&#x02013;<lpage>72</lpage>.<pub-id pub-id-type="pmid">22094977</pub-id></mixed-citation></ref><ref id="C96"><label>96</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sugui</surname><given-names>JA</given-names></name>, <name><surname>Pardo</surname><given-names>J</given-names></name>, <name><surname>Chang</surname><given-names>YC</given-names></name>, <name><surname>Zarember</surname><given-names>KA</given-names></name>, <name><surname>Nardone</surname><given-names>G</given-names></name>, <name><surname>Galvez</surname><given-names>EM</given-names></name>, <etal><italic>et al.</italic></etal></person-group>
<article-title>Gliotoxin is a virulence factor of <italic>Aspergillus fumigatus</italic>: gliP deletion attenuates virulence in mice immunosuppressed with hydrocortisone</article-title>. <source>Eukaryot Cell</source>
<year>2007</year>;<volume>6</volume>:<fpage>1562</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">17601876</pub-id></mixed-citation></ref><ref id="C97"><label>97</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diana</surname><given-names>M</given-names></name>, <name><surname>Peana</surname><given-names>AT</given-names></name>, <name><surname>Sirca</surname><given-names>D</given-names></name>, <name><surname>Lintas</surname><given-names>A</given-names></name>, <name><surname>Melis</surname><given-names>E</given-names></name>, <name><surname>Enrico</surname><given-names>P</given-names></name></person-group>
<article-title>Crucial role of acetaldehyde in alcohol activation of the mesolimbic dopamine system</article-title>. <source>Ann NY Acad Sci</source>
<year>2008</year>;<volume>1139</volume>:<fpage>307</fpage>&#x02013;<lpage>17</lpage>.<pub-id pub-id-type="pmid">18991876</pub-id></mixed-citation></ref><ref id="C98"><label>98</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>SC</given-names></name>, <name><surname>Chai</surname><given-names>LY</given-names></name>, <name><surname>Joosten</surname><given-names>LA</given-names></name>, <name><surname>Vecchiarelli</surname><given-names>A</given-names></name>, <name><surname>Hube</surname><given-names>V</given-names></name>, <name><surname>Van der Meer</surname><given-names>JW</given-names></name>, <etal><italic>et al.</italic></etal></person-group>
<article-title><italic>Candida albicans</italic> releases soluble factors that potentiate cytokine production by human cells through a protease-activated receptor 1- and 2-independent pathway</article-title>. <source>Infect Immun</source>
<year>2010</year>;<volume>78</volume>:<fpage>393</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">19858310</pub-id></mixed-citation></ref><ref id="C99"><label>99</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>X</given-names></name>, <name><surname>Chauhan</surname><given-names>A</given-names></name>, <name><surname>Sheikh</surname><given-names>AM</given-names></name>, <name><surname>Patil</surname><given-names>S</given-names></name>, <name><surname>Chauhan</surname><given-names>V</given-names></name>, <name><surname>Li</surname><given-names>XM</given-names></name>, <etal><italic>et al.</italic></etal></person-group>
<article-title>Elevated immune response in the brain of autistic patients</article-title>. <source>J Neuroimmunol</source>
<year>2009</year>;<volume>207</volume>:<fpage>111</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="pmid">19157572</pub-id></mixed-citation></ref><ref id="C100"><label>100</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reichelt</surname><given-names>KL</given-names></name>, <name><surname>Knivsberg</surname><given-names>AM</given-names></name></person-group>
<article-title>Can the pathophysiology of autism be explained by the nature of the discovered urine peptides?</article-title>
<source>Nutr Neurosci</source>
<year>2003</year>;<volume>6</volume>:<fpage>19</fpage>&#x02013;<lpage>28</lpage>.<pub-id pub-id-type="pmid">12608733</pub-id></mixed-citation></ref><ref id="C101"><label>101</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hopper</surname><given-names>DG</given-names></name>, <name><surname>Bolton</surname><given-names>VE</given-names></name>, <name><surname>Guilford</surname><given-names>FT</given-names></name>, <name><surname>Straus</surname><given-names>DC</given-names></name></person-group>
<article-title>Mycotoxin detection in human samples from patients exposed to environmental molds</article-title>. <source>Int J Sci</source>
<year>2009</year>;<volume>10</volume>:<fpage>1465</fpage>&#x02013;<lpage>75</lpage>.</mixed-citation></ref><ref id="C102"><label>102</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yap</surname><given-names>IK</given-names></name>, <name><surname>Angley</surname><given-names>M</given-names></name>, <name><surname>Veselkov</surname><given-names>KA</given-names></name>, <name><surname>Holmes</surname><given-names>E</given-names></name>, <name><surname>Lindon</surname><given-names>JC</given-names></name>, <name><surname>Nicholson</surname><given-names>JK</given-names></name></person-group>
<article-title>Urinary metabolic phenotyping differentiates children with autism from their unaffected siblings and age-matched controls</article-title>. <source>J Proteome Res</source>
<year>2010</year>;<volume>9</volume>:<fpage>2996</fpage>&#x02013;<lpage>3004</lpage>.<pub-id pub-id-type="pmid">20337404</pub-id></mixed-citation></ref><ref id="C103"><label>103</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clayton</surname><given-names>TA</given-names></name></person-group>
<article-title>Metabolic differences underlying two distinct rat urinary phenotypes, a suggested role for gut microbial metabolism of phenylalanine and a possible connection to autism</article-title>. <source>FEBS Lett</source>
<year>2012</year>;<volume>586</volume>:<fpage>956</fpage>&#x02013;<lpage>61</lpage>.<pub-id pub-id-type="pmid">22306194</pub-id></mixed-citation></ref><ref id="C104"><label>104</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kost</surname><given-names>NV</given-names></name>, <name><surname>Sokolov</surname><given-names>OY</given-names></name>, <name><surname>Kurasova</surname><given-names>OB</given-names></name>, <name><surname>Dmitriev</surname><given-names>AD</given-names></name>, <name><surname>Tarakanova</surname><given-names>JN</given-names></name>, <name><surname>Gabaeva</surname><given-names>MV</given-names></name>, <etal><italic>et al.</italic></etal></person-group>
<article-title>Beta-casomorphins-7 in infants on different type of feeding and different levels of psychomotor development</article-title>. <source>Peptides</source>
<year>2009</year>;<volume>30</volume>:<fpage>1854</fpage>&#x02013;<lpage>60</lpage>.<pub-id pub-id-type="pmid">19576256</pub-id></mixed-citation></ref><ref id="C105"><label>105</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trezza</surname><given-names>V</given-names></name>, <name><surname>Damsteegt</surname><given-names>R</given-names></name>, <name><surname>Achterberg</surname><given-names>EJ</given-names></name>, <name><surname>Vanderschuren</surname><given-names>LJ</given-names></name></person-group>
<article-title>Nucleus accumbens &#x003bc;-opioid receptors mediate social reward</article-title>. <source>J Neurosci</source>
<year>2011</year>;<volume>31</volume>:<fpage>6362</fpage>&#x02013;<lpage>70</lpage>.<pub-id pub-id-type="pmid">21525276</pub-id></mixed-citation></ref><ref id="C106"><label>106</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reichelt</surname><given-names>KL</given-names></name>, <name><surname>Tveiten</surname><given-names>D</given-names></name>, <name><surname>Knivsberg</surname><given-names>AM</given-names></name>, <name><surname>Bronstad</surname><given-names>G</given-names></name></person-group>
<article-title>Peptide's role in autism with emphasis on exorphins</article-title>. <source>Microbiol Ecol Health Dis</source>
<year>2012</year>;<volume>23</volume>:<fpage>18958</fpage>.</mixed-citation></ref><ref id="C107"><label>107</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leboyer</surname><given-names>M</given-names></name>, <name><surname>Bouvard</surname><given-names>MP</given-names></name>, <name><surname>Launay</surname><given-names>JM</given-names></name>, <name><surname>Recasens</surname><given-names>C</given-names></name>, <name><surname>Plumet</surname><given-names>MH</given-names></name>, <name><surname>Waller-Perotte</surname><given-names>D</given-names></name>, <etal><italic>et al.</italic></etal></person-group>
<article-title>Opiate hypothesis in infantile autism? Therapeutic trials with naltrexone</article-title>. <source>Encephale</source>
<year>1993</year>;<volume>19</volume>:<fpage>95</fpage>&#x02013;<lpage>102</lpage>.<pub-id pub-id-type="pmid">8275903</pub-id></mixed-citation></ref><ref id="C108"><label>108</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cie&#x0015b;li&#x00144;ska</surname><given-names>A</given-names></name>, <name><surname>Kostyra</surname><given-names>E</given-names></name>, <name><surname>Kostyra</surname><given-names>H</given-names></name>, <name><surname>Ole&#x00144;ski</surname><given-names>K</given-names></name>, <name><surname>Fiedorowicz</surname><given-names>E</given-names></name>, <name><surname>Kaminski</surname><given-names>S</given-names></name></person-group>
<article-title>Milk from cows of different &#x003b2;-casein genotypes as a source of &#x003b2;-casomorphin-7</article-title>. <source>Int J Food Sci Nutr</source>
<year>2012</year>;<volume>63</volume>:<fpage>426</fpage>&#x02013;<lpage>30</lpage>.<pub-id pub-id-type="pmid">22080615</pub-id></mixed-citation></ref><ref id="C109"><label>109</label><mixed-citation publication-type="journal"><collab>EFSA</collab>. <article-title>(European Food Safety Authority) Review of the potential health impact of &#x003b2;-casomorphins and related peptides</article-title>. <source>EFSA Sci Rep</source>
<year>2009</year>;<volume>231</volume>:<fpage>1</fpage>&#x02013;<lpage>107</lpage>.</mixed-citation></ref><ref id="C110"><label>110</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bouhet</surname><given-names>S</given-names></name>, <name><surname>Oswald</surname><given-names>IP</given-names></name></person-group>
<article-title>The effects of mycotoxins, fungal food contaminants, on the intestinal epithelial cell-derived innate immune response</article-title>. <source>Vet Immunol Immunopathol</source>
<year>2005</year>;<volume>108</volume>:<fpage>199</fpage>&#x02013;<lpage>209</lpage>.<pub-id pub-id-type="pmid">16144716</pub-id></mixed-citation></ref><ref id="C111"><label>111</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Belmadani</surname><given-names>A</given-names></name>, <name><surname>Tramu</surname><given-names>G</given-names></name>, <name><surname>Betbeder</surname><given-names>AM</given-names></name>, <name><surname>Steyn</surname><given-names>PS</given-names></name>, <name><surname>Creppy</surname><given-names>EE</given-names></name></person-group>
<article-title>Regional selectivity to ochratoxin A, distribution and cytotoxicity in rat brain</article-title>. <source>Arch Toxicol</source>
<year>1998</year>;<volume>72</volume>:<fpage>656</fpage>&#x02013;<lpage>62</lpage>.<pub-id pub-id-type="pmid">9851682</pub-id></mixed-citation></ref><ref id="C112"><label>112</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Puel</surname><given-names>O</given-names></name>, <name><surname>Galtier</surname><given-names>P</given-names></name>, <name><surname>Oswald</surname><given-names>IP</given-names></name></person-group>
<article-title>Biosynthesis and toxicological effects of patulin</article-title>. <source>Toxins</source>
<year>2010</year>;<volume>2</volume>:<fpage>613</fpage>&#x02013;<lpage>31</lpage>.<pub-id pub-id-type="pmid">22069602</pub-id></mixed-citation></ref><ref id="C113"><label>113</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sava</surname><given-names>V</given-names></name>, <name><surname>Reunova</surname><given-names>O</given-names></name>, <name><surname>Velasquez</surname><given-names>A</given-names></name>, <name><surname>Harbison</surname><given-names>R</given-names></name>, <name><surname>S&#x000e0;nchez-Ramos</surname><given-names>J</given-names></name></person-group>
<article-title>Acute neurotoxic effects of the fungal metabolite ochratoxin-A</article-title>. <source>Neurotoxicology</source>
<year>2006</year>;<volume>27</volume>:<fpage>82</fpage>&#x02013;<lpage>92</lpage>.<pub-id pub-id-type="pmid">16140385</pub-id></mixed-citation></ref><ref id="C114"><label>114</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doi</surname><given-names>K</given-names></name>, <name><surname>Uetsuka</surname><given-names>K</given-names></name></person-group>
<article-title>Mechanisms of mycotoxin-induced neurotoxicity through oxidative stress-associated pathways</article-title>. <source>Int J Mol Sci</source>
<year>2011</year>;<volume>12</volume>:<fpage>5213</fpage>&#x02013;<lpage>37</lpage>.<pub-id pub-id-type="pmid">21954354</pub-id></mixed-citation></ref><ref id="C115"><label>115</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bouhet</surname><given-names>S</given-names></name>, <name><surname>Oswald</surname><given-names>IP</given-names></name></person-group>
<article-title>The intestine as a possible target for fumonisin toxicity</article-title>. <source>Mol Nutr Food Res</source>
<year>2007</year>;<volume>51</volume>:<fpage>925</fpage>&#x02013;<lpage>31</lpage>.<pub-id pub-id-type="pmid">17642075</pub-id></mixed-citation></ref><ref id="C116"><label>116</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Faber</surname><given-names>S</given-names></name>, <name><surname>Zinn</surname><given-names>GM</given-names></name>, <name><surname>Kern</surname><given-names>JC</given-names></name>, <name><surname>Kingston</surname><given-names>HM</given-names></name></person-group>
<article-title>The plasma zinc/serum copper ratio as a biomarker in children with autism spectrum disorders</article-title>. <source>Biomarkers</source>
<year>2009</year>;<volume>14</volume>:<fpage>171</fpage>&#x02013;<lpage>80</lpage>.<pub-id pub-id-type="pmid">19280374</pub-id></mixed-citation></ref><ref id="C117"><label>117</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Razafimanjato</surname><given-names>H</given-names></name>, <name><surname>Garmy</surname><given-names>N</given-names></name>, <name><surname>Guo</surname><given-names>XJ</given-names></name>, <name><surname>Varini</surname><given-names>K</given-names></name>, <name><surname>Di Scala</surname><given-names>C</given-names></name>, <name><surname>Di Pasquale</surname><given-names>E</given-names></name>, <etal><italic>et al.</italic></etal></person-group>
<article-title>The food-associated fungal neurotoxin ochratoxin A inhibits the absorption of glutamate by astrocytes through a decrease in cell surface expression of the excitatory amino-acid transporters GLAST and GLT-1</article-title>. <source>Neurotoxicology</source>
<year>2010</year>;<volume>31</volume>:<fpage>475</fpage>&#x02013;<lpage>84</lpage>.<pub-id pub-id-type="pmid">20558201</pub-id></mixed-citation></ref><ref id="C118"><label>118</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fioramonti</surname><given-names>J</given-names></name>, <name><surname>Dupuy</surname><given-names>C</given-names></name>, <name><surname>Dupuy</surname><given-names>J</given-names></name>, <name><surname>Bueno</surname><given-names>L</given-names></name></person-group>
<article-title>The mycotoxin deoxynivalenol delays gastric emptying trough serotonin-3 receptors in rodents</article-title>. <source>J Pharmacol</source>
<year>1993</year>;<volume>266</volume>:<fpage>255</fpage>&#x02013;<lpage>60</lpage>.</mixed-citation></ref><ref id="C119"><label>119</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prelusky</surname><given-names>DB</given-names></name></person-group>
<article-title>The effect of low-level deoxynivalenol on neurotransmitter levels measured in pig cerebral spinal fluid</article-title>. <source>J Environ Sci Health B</source>
<year>1993</year>;<volume>28</volume>:<fpage>731</fpage>&#x02013;<lpage>61</lpage>.<pub-id pub-id-type="pmid">7903675</pub-id></mixed-citation></ref><ref id="C120"><label>120</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Girish</surname><given-names>CK</given-names></name>, <name><surname>MacDonald</surname><given-names>EJ</given-names></name>, <name><surname>Scheinin</surname><given-names>M</given-names></name>, <name><surname>Smith</surname><given-names>TK</given-names></name></person-group>
<article-title>Effects of feedborne <italic>Fusarium</italic> mycotoxins on brain regional neurochemistry of Turkeys</article-title>. <source>Poult Sci</source>
<year>2008</year>;<volume>87</volume>:<fpage>1295</fpage>&#x02013;<lpage>302</lpage>.<pub-id pub-id-type="pmid">18577608</pub-id></mixed-citation></ref><ref id="C121"><label>121</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Sarro</surname><given-names>GB</given-names></name>, <name><surname>Donato</surname><given-names>A</given-names></name>, <name><surname>Bagetta</surname><given-names>G</given-names></name>, <name><surname>Pujia</surname><given-names>A</given-names></name>, <name><surname>Nistic&#x000f2;</surname><given-names>G</given-names></name></person-group>
<article-title>Behavioural and electrocortical spectrum power changes after intraventricular injection of patulin in rats</article-title>. <source>Arch Toxicol</source>
<year>1984</year>;<volume>7</volume>:<fpage>420</fpage>&#x02013;<lpage>4</lpage>.</mixed-citation></ref><ref id="C122"><label>122</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gardiner</surname><given-names>DM</given-names></name>, <name><surname>Waring</surname><given-names>P</given-names></name>, <name><surname>Howlett</surname><given-names>BJ</given-names></name></person-group>
<article-title>The epipolythiodioxopiperazine (ETP) class of fungal toxins: distribution, mode of action, functions and biosynthesis</article-title>. <source>Microbiology</source>
<year>2005</year>;<volume>151</volume>:<fpage>1021</fpage>&#x02013;<lpage>32</lpage>.<pub-id pub-id-type="pmid">15817772</pub-id></mixed-citation></ref><ref id="C123"><label>123</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lewis</surname><given-names>RE</given-names></name>, <name><surname>Wiederhold</surname><given-names>NP</given-names></name>, <name><surname>Chi</surname><given-names>J</given-names></name>, <name><surname>Han</surname><given-names>XY</given-names></name>, <name><surname>Komanduri</surname><given-names>KV</given-names></name>, <name><surname>Kontoyiannis</surname><given-names>DP</given-names></name>, <etal><italic>et al.</italic></etal></person-group>
<article-title>Detection of gliotoxin in experimental and human aspergillosis</article-title>. <source>Infect Immun</source>
<year>2005</year>;<volume>73</volume>:<fpage>635</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="pmid">15618207</pub-id></mixed-citation></ref><ref id="C124"><label>124</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scharf</surname><given-names>DH</given-names></name>, <name><surname>Remme</surname><given-names>N</given-names></name>, <name><surname>Heinekamp</surname><given-names>T</given-names></name>, <name><surname>Hortschansky</surname><given-names>P</given-names></name>, <name><surname>Brakhage</surname><given-names>AE</given-names></name>, <name><surname>Hertweck</surname><given-names>C</given-names></name></person-group>
<article-title>Transannular disulfide formation in gliotoxin biosynthesis and its role in self-resistance of the human pathogen <italic>Aspergillus fumigatus</italic></article-title>. <source>J Am Chem Soc</source>
<year>2010</year>;<volume>132</volume>:<fpage>10136</fpage>&#x02013;<lpage>41</lpage>.<pub-id pub-id-type="pmid">20593880</pub-id></mixed-citation></ref><ref id="C125"><label>125</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pennesi</surname><given-names>CM</given-names></name>, <name><surname>Klein</surname><given-names>LC</given-names></name></person-group>
<article-title>Effectiveness of the gluten-free, casein-free diet for children diagnosed with autism spectrum disorder: based on parental report</article-title>. <source>Nutr Neurosci</source>
<year>2012</year>;<volume>15</volume>:<fpage>85</fpage>&#x02013;<lpage>91</lpage>.<pub-id pub-id-type="pmid">22564339</pub-id></mixed-citation></ref><ref id="C126"><label>126</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cass</surname><given-names>H</given-names></name>, <name><surname>Gringras</surname><given-names>P</given-names></name>, <name><surname>March</surname><given-names>J</given-names></name>, <name><surname>McKendrick</surname><given-names>I</given-names></name>, <name><surname>O'Hare</surname><given-names>AE</given-names></name>, <name><surname>Owen</surname><given-names>L</given-names></name>, <etal><italic>et al.</italic></etal></person-group>
<article-title>Absence of urinary opioid peptides in children with autism</article-title>. <source>Arch Dis Child</source>
<year>2008</year>;<volume>93</volume>:<fpage>745</fpage>&#x02013;<lpage>50</lpage>.<pub-id pub-id-type="pmid">18337276</pub-id></mixed-citation></ref><ref id="C127"><label>127</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barcia</surname><given-names>G</given-names></name>, <name><surname>Posar</surname><given-names>A</given-names></name>, <name><surname>Santucci</surname><given-names>M</given-names></name>, <name><surname>Parmeggiani</surname><given-names>A</given-names></name></person-group>
<article-title>Autism and coeliac disease</article-title>. <source>J Autism Dev Disord</source>
<year>2008</year>;<volume>38</volume>:<fpage>407</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="pmid">17985220</pub-id></mixed-citation></ref><ref id="C128"><label>128</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Genuis</surname><given-names>SJ</given-names></name>, <name><surname>Bouchard</surname><given-names>TP</given-names></name></person-group>
<article-title>Celiac disease presenting as autism</article-title>. <source>J Child Neurol</source>
<year>2010</year>;<volume>25</volume>:<fpage>114</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">19564647</pub-id></mixed-citation></ref><ref id="C129"><label>129</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Batista</surname><given-names>IC</given-names></name>, <name><surname>Gandolfi</surname><given-names>L</given-names></name>, <name><surname>Nobrega</surname><given-names>YK</given-names></name>, <name><surname>Almeida</surname><given-names>RC</given-names></name>, <name><surname>Almeida</surname><given-names>RM</given-names></name>, <etal><italic>et al.</italic></etal></person-group>
<article-title>Autism spectrum disorder and celiac disease: no evidence for a link</article-title>. <source>Arq Neuropsiquiatr</source>
<year>2012</year>;<volume>70</volume>:<fpage>28</fpage>&#x02013;<lpage>33</lpage>.<pub-id pub-id-type="pmid">22218470</pub-id></mixed-citation></ref><ref id="C130"><label>130</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Griffin</surname><given-names>M</given-names></name>, <name><surname>Casadio</surname><given-names>R</given-names></name>, <name><surname>Bergamini</surname><given-names>CM</given-names></name></person-group>
<article-title>Transglutaminases: nature's biological glues</article-title>. <source>Biochem J</source>
<year>2002</year>;<volume>368</volume>:<fpage>377</fpage>&#x02013;<lpage>96</lpage>.<pub-id pub-id-type="pmid">12366374</pub-id></mixed-citation></ref><ref id="C131"><label>131</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Facchiano</surname><given-names>F</given-names></name>, <name><surname>Deloye</surname><given-names>F</given-names></name>, <name><surname>Doussau</surname><given-names>F</given-names></name>, <name><surname>Innamorati</surname><given-names>G</given-names></name>, <name><surname>Ashton</surname><given-names>AC</given-names></name>, <name><surname>Dolly</surname><given-names>JO</given-names></name>, <etal><italic>et al.</italic></etal></person-group>
<article-title>Transglutaminase participates in the blockade of neurotransmitter release by tetanus toxin: evidence for a novel biological function</article-title>. <source>Amino Acids</source>
<year>2010</year>;<volume>39</volume>:<fpage>257</fpage>&#x02013;<lpage>69</lpage>.<pub-id pub-id-type="pmid">20084413</pub-id></mixed-citation></ref><ref id="C132"><label>132</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosenspire</surname><given-names>A</given-names></name>, <name><surname>Yoo</surname><given-names>W</given-names></name>, <name><surname>Menard</surname><given-names>S</given-names></name>, <name><surname>Torres</surname><given-names>AR</given-names></name></person-group>
<article-title>Autism spectrum disorders are associated with an elevated autoantibody response to tissue transglutaminase-2</article-title>. <source>Autism Res</source>
<year>2011</year>;<volume>4</volume>:<fpage>242</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">21506289</pub-id></mixed-citation></ref><ref id="C133"><label>133</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ashwood</surname><given-names>P</given-names></name>, <name><surname>Krakowiak</surname><given-names>P</given-names></name>, <name><surname>Hertz-Picciotto</surname><given-names>I</given-names></name>, <name><surname>Hansen</surname><given-names>R</given-names></name>, <name><surname>Pessah</surname><given-names>I</given-names></name>, <name><surname>Van de Water</surname><given-names>J</given-names></name></person-group>
<article-title>Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome</article-title>. <source>Brain Behav Immun</source>
<year>2011</year>;<volume>25</volume>:<fpage>40</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="pmid">20705131</pub-id></mixed-citation></ref><ref id="C134"><label>134</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boulanger</surname><given-names>LM</given-names></name></person-group>
<article-title>Immune proteins in brain development and synaptic plasticity</article-title>. <source>Neuron</source>
<year>2009</year>;<volume>64</volume>:<fpage>93</fpage>&#x02013;<lpage>109</lpage>.<pub-id pub-id-type="pmid">19840552</pub-id></mixed-citation></ref><ref id="C135"><label>135</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coutellier</surname><given-names>L</given-names></name>, <name><surname>Beraki</surname><given-names>S</given-names></name>, <name><surname>Ardestani</surname><given-names>PM</given-names></name>, <name><surname>Saw</surname><given-names>NL</given-names></name>, <name><surname>Shamloo</surname><given-names>M</given-names></name></person-group>
<article-title>Npas4: a neuronal transcription factor with a key role in social and cognitive functions relevant to developmental disorders</article-title>. <source>PLoS ONE</source>
<year>2012</year>;<volume>7</volume>:<fpage>e46604</fpage>.<pub-id pub-id-type="pmid">23029555</pub-id></mixed-citation></ref><ref id="C136"><label>136</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lintas</surname><given-names>C</given-names></name>, <name><surname>Sacco</surname><given-names>R</given-names></name>, <name><surname>Persico</surname><given-names>AM</given-names></name></person-group>
<article-title>Genome-wide expression studies in autism spectrum disorder, Rett syndrome, and Down syndrome</article-title>. <source>Neurobiol Dis</source>
<year>2012</year>;<volume>45</volume>:<fpage>57</fpage>&#x02013;<lpage>68</lpage>.<pub-id pub-id-type="pmid">21130877</pub-id></mixed-citation></ref><ref id="C137"><label>137</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ziats</surname><given-names>MN</given-names></name>, <name><surname>Rennert</surname><given-names>OM</given-names></name></person-group>
<article-title>Expression profiling of autism candidate genes during human brain development implicates central immune signaling pathways</article-title>. <source>PLoS ONE</source>
<year>2011</year>;<volume>6</volume>:<fpage>e24691</fpage>.<pub-id pub-id-type="pmid">21935439</pub-id></mixed-citation></ref><ref id="C138"><label>138</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharif</surname><given-names>O</given-names></name>, <name><surname>Bolshakov</surname><given-names>NV</given-names></name>, <name><surname>Raines</surname><given-names>S</given-names></name>, <name><surname>Newham</surname><given-names>P</given-names></name>, <name><surname>Perkins</surname><given-names>ND</given-names></name></person-group>
<article-title>Transcriptional profiling of the LPS induced NF-&#x003ba;B response in macrophages</article-title>. <source>BMC Immunol</source>
<year>2007</year>;<volume>8</volume>:<fpage>1</fpage>.<pub-id pub-id-type="pmid">17222336</pub-id></mixed-citation></ref><ref id="C139"><label>139</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pahl</surname><given-names>HL</given-names></name></person-group>
<article-title>Activators and target genes of Rel/NF-&#x003ba;B transcription factors</article-title>. <source>Oncogene</source>
<year>1999</year>;<volume>18</volume>:<fpage>6853</fpage>&#x02013;<lpage>66</lpage>.<pub-id pub-id-type="pmid">10602461</pub-id></mixed-citation></ref><ref id="C140"><label>140</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perkins</surname><given-names>ND</given-names></name></person-group>
<article-title>NF-&#x003ba;B: Tumor promoter or suppressor?</article-title>
<source>Trends Cell Biol</source>
<year>2004</year>;<volume>14</volume>:<fpage>64</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">15102437</pub-id></mixed-citation></ref><ref id="C141"><label>141</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naik</surname><given-names>US</given-names></name>, <name><surname>Gangadharan</surname><given-names>C</given-names></name>, <name><surname>Abbagni</surname><given-names>K</given-names></name>, <name><surname>Nagalla</surname><given-names>B</given-names></name>, <name><surname>Dasari</surname><given-names>N</given-names></name>, <name><surname>Manna</surname><given-names>SK</given-names></name></person-group>
<article-title>A study of nuclear factor-kappaB in childhood autism</article-title>. <source>PLoS ONE</source>
<year>2011</year>;<volume>6</volume>:<fpage>e19488</fpage>.<pub-id pub-id-type="pmid">21573053</pub-id></mixed-citation></ref><ref id="C142"><label>142</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Young</surname><given-names>AMH</given-names></name>, <name><surname>Campbell</surname><given-names>E</given-names></name>, <name><surname>Lynch</surname><given-names>S</given-names></name>, <name><surname>Suckling</surname><given-names>J</given-names></name>, <name><surname>Powis</surname><given-names>SJ</given-names></name></person-group>
<article-title>Aberrant NF-kappaB expression in autism spectrum condition: a mechanism for neuroinflammation</article-title>. <source>Front Psychiatry</source>
<year>2011</year>;<volume>2</volume>:<fpage>27</fpage>.<pub-id pub-id-type="pmid">21629840</pub-id></mixed-citation></ref><ref id="C143"><label>143</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gopee</surname><given-names>NV</given-names></name>, <name><surname>He</surname><given-names>Q</given-names></name>, <name><surname>Sharma</surname><given-names>RP</given-names></name></person-group>
<article-title>Fumosin B<sub>1</sub>-induced apoptosis is associated with delayed inhibition of protein kinase C, nuclear factor-&#x003ba;B and tumor necrosis factor &#x003b1; in LLC-PK<sub>1</sub> cells</article-title>. <source>Chem Biol Interact</source>
<year>2003</year>;<volume>146</volume>:<fpage>131</fpage>&#x02013;<lpage>45</lpage>.<pub-id pub-id-type="pmid">14597127</pub-id></mixed-citation></ref><ref id="C144"><label>144</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cavin</surname><given-names>C</given-names></name>, <name><surname>Delatour</surname><given-names>T</given-names></name>, <name><surname>Marin-Kuan</surname><given-names>M</given-names></name>, <name><surname>Fenaille</surname><given-names>F</given-names></name>, <name><surname>Holzhauser</surname><given-names>D</given-names></name>, <name><surname>Guignard</surname><given-names>G</given-names></name>, <etal><italic>et al.</italic></etal></person-group>
<article-title>Ochratoxin A-mediated DNA and protein damage: Roles of nitrosative and oxidative stresses</article-title>. <source>Toxicol Sci</source>
<year>2009</year>;<volume>110</volume>:<fpage>84</fpage>&#x02013;<lpage>94</lpage>.<pub-id pub-id-type="pmid">19414514</pub-id></mixed-citation></ref><ref id="C145"><label>145</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>SS</given-names></name>, <name><surname>Zhou</surname><given-names>HR</given-names></name>, <name><surname>Pestka</surname><given-names>JJ</given-names></name></person-group>
<article-title>Effects of vomitoxin (deoxynivalenol) on the binding of transcription factors AP-1, NF-kappaB, and NF-IL6 in raw 264.7 macrophage cells</article-title>. <source>J Toxicol Environ Health A</source>
<year>2002</year>;<volume>65</volume>:<fpage>1161</fpage>&#x02013;<lpage>80</lpage>.<pub-id pub-id-type="pmid">12167214</pub-id></mixed-citation></ref><ref id="C146"><label>146</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pestka</surname><given-names>JJ</given-names></name></person-group>
<article-title>Mechanisms of deoxynivalenol-induced gene expression and apoptosis</article-title>. <source>Food Addit Contam A Chem Anal Control Expo Risk Assess</source>
<year>2008</year>;<volume>25</volume>:<fpage>1128</fpage>&#x02013;<lpage>40</lpage>.</mixed-citation></ref><ref id="C147"><label>147</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pestka</surname><given-names>JJ</given-names></name></person-group>
<article-title>Deoxynivalenol-induced proinflammatory gene expression: mechanisms and pathological sequelae</article-title>. <source>Toxin</source>
<year>2010</year>;<volume>2</volume>:<fpage>1300</fpage>&#x02013;<lpage>17</lpage>.</mixed-citation></ref><ref id="C148"><label>148</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moon</surname><given-names>Y</given-names></name>, <name><surname>Pestka</surname><given-names>JJ</given-names></name></person-group>
<article-title>Vomitoxin-induced cyclooxygenase-2 gene expression in macrophage mediated by activation of ERK and p38 but not JNK mitogen-activated protein kinases</article-title>. <source>Toxicol Sci</source>
<year>2002</year>;<volume>69</volume>:<fpage>373</fpage>&#x02013;<lpage>82</lpage>.<pub-id pub-id-type="pmid">12377986</pub-id></mixed-citation></ref><ref id="C149"><label>149</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sajdel-Sulkowska</surname><given-names>EM</given-names></name>, <name><surname>Xu</surname><given-names>M</given-names></name>, <name><surname>Koibuchi</surname><given-names>N</given-names></name></person-group>
<article-title>Increase in cerebellar neurotrophin-3 and oxidative stress markers in autism</article-title>. <source>Cerebellum</source>
<year>2009</year>;<volume>8</volume>:<fpage>366</fpage>&#x02013;<lpage>72</lpage>.<pub-id pub-id-type="pmid">19357934</pub-id></mixed-citation></ref><ref id="C150"><label>150</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ziats</surname><given-names>NM</given-names></name>, <name><surname>Rennert</surname><given-names>OM</given-names></name></person-group>
<article-title>Sex-biased gene expression in the developing brain: implications for autism spectrum disorders</article-title>. <source>Mol Autism</source>
<year>2013</year>;<volume>4</volume>:<fpage>10</fpage>.<pub-id pub-id-type="pmid">23651621</pub-id></mixed-citation></ref><ref id="C151"><label>151</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ueta</surname><given-names>E</given-names></name>, <name><surname>Kodama</surname><given-names>M</given-names></name>, <name><surname>Sumino</surname><given-names>Y</given-names></name>, <name><surname>Kurome</surname><given-names>M</given-names></name>, <name><surname>Ohta</surname><given-names>K</given-names></name>, <name><surname>Katagiru</surname><given-names>R</given-names></name>, <etal><italic>et al.</italic></etal></person-group>
<article-title>Gender-dependent differences in the incidence of ochratoxin A-induced neural tube defects in the Pdn/Pdn mouse</article-title>. <source>Congenit Anom (Kyoto)</source>
<year>2010</year>;<volume>50</volume>:<fpage>29</fpage>&#x02013;<lpage>39</lpage>.<pub-id pub-id-type="pmid">20201966</pub-id></mixed-citation></ref><ref id="C152"><label>152</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barrionuevo</surname><given-names>F</given-names></name>, <name><surname>Scherer</surname><given-names>G</given-names></name></person-group>
<article-title>SOX E genes: SOX9 and SOX8 in mammalian testis development</article-title>. <source>Int J Biochem Cell Biol</source>
<year>2010</year>;<volume>42</volume>:<fpage>433</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="pmid">19647095</pub-id></mixed-citation></ref><ref id="C153"><label>153</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghahramani Seno</surname><given-names>MM</given-names></name>, <name><surname>Hu</surname><given-names>P</given-names></name>, <name><surname>Gwadry</surname><given-names>FG</given-names></name>, <name><surname>Pinto</surname><given-names>D</given-names></name>, <name><surname>Marshall</surname><given-names>CR</given-names></name>, <etal><italic>et al.</italic></etal></person-group>
<article-title>Gene and miRNA expression profiles in autism spectrum disorders</article-title>. <source>Brain Res</source>
<year>2011</year>;<volume>1380</volume>:<fpage>85</fpage>&#x02013;<lpage>97</lpage>.<pub-id pub-id-type="pmid">20868653</pub-id></mixed-citation></ref><ref id="C154"><label>154</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tryphonas</surname><given-names>H</given-names></name>, <name><surname>Bondy</surname><given-names>G</given-names></name>, <name><surname>Miller</surname><given-names>JD</given-names></name>, <name><surname>Lacroix</surname><given-names>F</given-names></name>, <name><surname>Hodgen</surname><given-names>M</given-names></name>, <name><surname>Mcguire</surname><given-names>P</given-names></name>, <etal><italic>et al.</italic></etal></person-group>
<article-title>Effects of fumonisin B1 on the immune system of Sprague-Dawley rats following a 14-day oral (gavage) exposure</article-title>. <source>Fundam Appl Toxicol</source>
<year>1997</year>;<volume>39</volume>:<fpage>53</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">9325027</pub-id></mixed-citation></ref><ref id="C155"><label>155</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marin</surname><given-names>DE</given-names></name>, <name><surname>Taranu</surname><given-names>I</given-names></name>, <name><surname>Pascale</surname><given-names>F</given-names></name>, <name><surname>Lionide</surname><given-names>A</given-names></name>, <name><surname>Burlacu</surname><given-names>R</given-names></name>, <name><surname>Bailly</surname><given-names>JD</given-names></name>, <etal><italic>et al.</italic></etal></person-group>
<article-title>Sex-related differences in the immune response of weanling piglets exposed to low doses of fumonisin extract</article-title>. <source>Br J Nutr</source>
<year>2006</year>;<volume>95</volume>:<fpage>1185</fpage>&#x02013;<lpage>92</lpage>.<pub-id pub-id-type="pmid">16768843</pub-id></mixed-citation></ref><ref id="C156"><label>156</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baron-Cohen</surname><given-names>S</given-names></name>, <name><surname>Knickmeyer</surname><given-names>RC</given-names></name>, <name><surname>Belmonte</surname><given-names>MK</given-names></name></person-group>
<article-title>Sex differences in the brain: implications for explaining autism</article-title>. <source>Science</source>
<year>2005</year>;<volume>310</volume>:<fpage>819</fpage>&#x02013;<lpage>23</lpage>.<pub-id pub-id-type="pmid">16272115</pub-id></mixed-citation></ref><ref id="C157"><label>157</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chakrabarti</surname><given-names>B</given-names></name>, <name><surname>Dudbridge</surname><given-names>F</given-names></name>, <name><surname>Kent</surname><given-names>L</given-names></name>, <name><surname>Wheelwright</surname><given-names>S</given-names></name>, <name><surname>Hill-Cawthorne</surname><given-names>G</given-names></name>, <name><surname>Allison</surname><given-names>C</given-names></name>, <etal><italic>et al.</italic></etal></person-group>
<article-title>Genes related to sex steroids, neural growth, and social&#x02013;emotional behavior are associated with autistic traits, empathy, and Asperger syndrome</article-title>. <source>Autism Res</source>
<year>2009</year>;<volume>2</volume>:<fpage>157</fpage>&#x02013;<lpage>77</lpage>.<pub-id pub-id-type="pmid">19598235</pub-id></mixed-citation></ref><ref id="C158"><label>158</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sarachana</surname><given-names>T</given-names></name>, <name><surname>Xu</surname><given-names>M</given-names></name>, <name><surname>Wu</surname><given-names>RC</given-names></name>, <name><surname>Hu</surname><given-names>VW</given-names></name></person-group>
<article-title>Sex hormones in autism: androgens and estrogens differentially and reciprocally regulate RORA, a novel candidate gene for autism</article-title>. <source>PLoS ONE</source>
<year>2011</year>;<volume>6</volume>:<fpage>e17116</fpage>.<pub-id pub-id-type="pmid">21359227</pub-id></mixed-citation></ref><ref id="C159"><label>159</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fink-Gremmels</surname><given-names>J</given-names></name>, <name><surname>Malekinejad</surname><given-names>H</given-names></name></person-group>
<article-title>Clinical effects and biochemical mechanisms associated with exposure to the mycoestrogen zearalenone</article-title>. <source>Animal Feed Sci Technol</source>
<year>2007</year>;<volume>137</volume>:<fpage>326</fpage>&#x02013;<lpage>41</lpage>.</mixed-citation></ref><ref id="C160"><label>160</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeiner</surname><given-names>AR</given-names></name>, <name><surname>Kegg</surname><given-names>PS</given-names></name>, <name><surname>Blackburn</surname><given-names>M</given-names></name>, <name><surname>Stratton</surname><given-names>R</given-names></name></person-group>
<article-title>Gender differences in peak acetaldehyde concentration after an acute dose of ethanol</article-title>. <source>Neurobehav Toxicol Teratol</source>
<year>1983</year>;<volume>5</volume>:<fpage>201</fpage>&#x02013;<lpage>4</lpage>.<pub-id pub-id-type="pmid">6866196</pub-id></mixed-citation></ref><ref id="C161"><label>161</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Desbonnet</surname><given-names>L</given-names></name>, <name><surname>Clarke</surname><given-names>G</given-names></name>, <name><surname>Shanahan</surname><given-names>F</given-names></name>, <name><surname>Dinan</surname><given-names>TG</given-names></name>, <name><surname>Cryan</surname><given-names>JF</given-names></name></person-group>
<article-title>Microbiota is essential for social development in the mouse</article-title>. <source>Mol Psychiatry</source>
<year>2013</year>;<volume>65</volume>:<fpage>1</fpage>&#x02013;<lpage>2</lpage>.</mixed-citation></ref><ref id="C162"><label>162</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fish</surname><given-names>EN</given-names></name></person-group>
<article-title>The X-files in immunity: sex-based differences predispose immune responses</article-title>. <source>Nat Rev Immunol</source>
<year>2008</year>;<volume>8</volume>:<fpage>737</fpage>&#x02013;<lpage>44</lpage>.<pub-id pub-id-type="pmid">18728636</pub-id></mixed-citation></ref><ref id="C163"><label>163</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McClelland</surname><given-names>EE</given-names></name>, <name><surname>Smith</surname><given-names>JM</given-names></name></person-group>
<article-title>Gender specific differences in the immune response to infection</article-title>. <source>Arch Immunol Ther Exp (Warsz)</source>
<year>2011</year>;<volume>59</volume>:<fpage>203</fpage>&#x02013;<lpage>13</lpage>.<pub-id pub-id-type="pmid">21442309</pub-id></mixed-citation></ref><ref id="C164"><label>164</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loyd</surname><given-names>DR</given-names></name>, <name><surname>Murphy</surname><given-names>AZ</given-names></name></person-group>
<article-title>Androgen and estrogen (alpha) receptor localization on periaqueductal gray neurons projecting to the rostral ventromedial medulla in the male and female rat</article-title>. <source>J Chem Neuroanat</source>
<year>2008</year>;<volume>36</volume>:<fpage>216</fpage>&#x02013;<lpage>26</lpage>.<pub-id pub-id-type="pmid">18771723</pub-id></mixed-citation></ref><ref id="C165"><label>165</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loyd</surname><given-names>DR</given-names></name>, <name><surname>Morgan</surname><given-names>MM</given-names></name>, <name><surname>Murphy</surname><given-names>AZ</given-names></name></person-group>
<article-title>Morphine preferentially activates the periaqueductal gray&#x02013;rostral ventromedial medullary pathway in the male rat: a potential mechanism for sex differences in antinociception</article-title>. <source>Neuroscience</source>
<year>2007</year>;<volume>147</volume>:<fpage>456</fpage>&#x02013;<lpage>68</lpage>.<pub-id pub-id-type="pmid">17540508</pub-id></mixed-citation></ref><ref id="C166"><label>166</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loyd</surname><given-names>DR</given-names></name>, <name><surname>Morgan</surname><given-names>MM</given-names></name>, <name><surname>Murphy</surname><given-names>AZ</given-names></name></person-group>
<article-title>Sexually dimorphic activation of the periaqueductal gray&#x02013;rostral ventromedial medullary circuit during the development of tolerance to morphine in the rat</article-title>. <source>Eur J Neurosci</source>
<year>2008</year>;<volume>27</volume>:<fpage>1517</fpage>&#x02013;<lpage>24</lpage>.<pub-id pub-id-type="pmid">18364026</pub-id></mixed-citation></ref><ref id="C167"><label>167</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loyd</surname><given-names>DR</given-names></name>, <name><surname>Wang</surname><given-names>X</given-names></name>, <name><surname>Murphy</surname><given-names>AZ</given-names></name></person-group>
<article-title>Sex differences in &#x003bc;-opioid receptor expression in the rat midbrain periaqueductal gray are essential for eliciting sex differences in morphine analgesia</article-title>. <source>J Neurosci</source>
<year>2008</year>;<volume>28</volume>:<fpage>14007</fpage>&#x02013;<lpage>17</lpage>.<pub-id pub-id-type="pmid">19109484</pub-id></mixed-citation></ref></ref-list></back></article>